{"content":"<li class=\"n-box-item date-title\" data-end=\"1542085199\" data-start=\"1541998800\" data-txt=\"Monday, December 23, 2019\">Monday, November 12, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3408705\" data-ts=\"1542066456\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAGE\" target=\"_blank\">SAGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408705-sage-therapeuticsminus-3_2-leerink-first-to-rate-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sage Therapeutics -3.2% with Leerink first to rate Underperform</a></h4><ul>   <li>Sage Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a>) is <font color=\"red\">off 3.2%</font> after hours as Leerink initiates coverage at Underperform, seeing downside of more than a third in the current price.</li>    <li>The stock had 15 Buy ratings previously, according to Bloomberg's count, so Leerink is breaking the seal on the Sell signs.</li>    <li>The company's lead drug candidate, Zulresso, should be approved soon for postpartum depression, but that's a \"niche product with low peak sales, well below expectations,\" says analyst Marc Goodman. He adds that he's skeptical SAGE-217 (addressing major depressive disorder) can change the depression treatment paradigm. (h/t Bloomberg)</li>    <li>His price target of $80 implies 34% downside; <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color=\"red\">dropped 7.3%</font> during the regular session today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408705\" data-linked=\"Sage Therapeutics -3.2% with Leerink first to rate Underperform\" data-tweet=\"$SAGE - Sage Therapeutics -3.2% with Leerink first to rate Underperform https://seekingalpha.com/news/3408705-sage-therapeuticsminus-3_2-leerink-first-to-rate-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3408705-sage-therapeuticsminus-3_2-leerink-first-to-rate-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408703\" data-ts=\"1542064367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPAS\" target=\"_blank\">IPAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408703-pareteum-to-acquire-ipass-in-all-stock-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum to acquire iPass in all-stock deal</a></h4><ul>   <li>Fresh off a <a href=\"https://seekingalpha.com/news/3406239-ipass-gets-delisting-nasdaq-can-trade-counter\" target=\"_blank\">Nasdaq delisting</a>, iPass (NASDAQ:<a href='https://seekingalpha.com/symbol/IPAS' title='IPASS INC'>IPAS</a>) has a definitive deal to be <a href=\"https://seekingalpha.com/pr/17330842-pareteum-enters-de-nitive-agreement-acquire-ipass\" target=\"_blank\">acquired by Pareteum</a> (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) in an all-stock transaction.</li>    <li>IPass shareholders will get 1.17 shares of Pareteum stock in an exchange offer.</li>    <li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> is <font color=\"red\">off 1.9%</font> after hours, quoting at $2.10/share, and <font color=\"red\">declined 3.2%</font> today.</li>    <li>Pareteum says the deal will be immediately accretive to EPS and free cash flow after synergies (it expects more than $15M in annual cost synergies, with more than $12M of those to be realized in the first full combined quarter).</li>    <li>It also sees about $2M in GAAP earnings accretion, $5.5M non-GAAP, in the first full year after closing.</li>    <li>Pareteum will add more than 40 U.S. and international patents, some 500 new customers and a global network of more than 68M Wi-Fi hotspots.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3408703\" data-linked=\"Pareteum to acquire iPass in all-stock deal\" data-tweet=\"$IPAS $IPAS $TEUM - Pareteum to acquire iPass in all-stock deal https://seekingalpha.com/news/3408703-pareteum-to-acquire-ipass-in-all-stock-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3408703-pareteum-to-acquire-ipass-in-all-stock-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408701\" data-ts=\"1542063966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUYA\" target=\"_blank\">HUYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408701-huya-broadcastingplus-9_7-on-doubled-revenues-healthy-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huya Broadcasting +9.7% on doubled revenues, healthy guidance</a></h4><ul>   <li>Huya Broadcasting (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>) is <font color=\"green\">up 9.7%</font> after hours after beating expectations with its Q3 earnings, on revenues that more than doubled, and guiding for 90% revenues gains in the current quarter.</li>    <li>Revenues rose nearly 119% and the company swung to a net profit of 56.8M yuan (about $8.3M) from a year-ago net loss of 29.3M yuan. On a non-GAAP basis, the company hit a gain of 121M yuan ($17.6M) vs. a year-ago loss of 25.4M yuan.</li>    <li>Average monthly active users hit 99M (up 14.6%); average mobile MAUs were 49.4M (up 28.2%).</li>    <li>Total paying users hit 4.2M, up 37.8% Y/Y.</li>    <li>Liquidity was 5.87B yuan (about $855M) as of quarter's end; net cash from operations was 237.7M yuan (about $34.6M), up from a year-ago 87.2M yuan.</li>    <li>For Q4, it's guiding to revenues of 1.4B-1.44B yuan (about $201M-$207M, and marking growth of 88.9%-94.3% in renminbi terms).</li>    <li>\n<a href=\"http://ir.huya.com/\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408692-huya-broadcasting-beats-0_04-beats-revenue\" target=\"_blank\">Huya Broadcasting beats by $0.04, beats on revenue</a> (Nov. 12 2018)</li>   <li><a href=\"https://seekingalpha.com/pr/17330832-huya-reports-third-quarter-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3408701\" data-linked=\"Huya Broadcasting +9.7% on doubled revenues, healthy guidance\" data-tweet=\"$HUYA - Huya Broadcasting +9.7% on doubled revenues, healthy guidance https://seekingalpha.com/news/3408701-huya-broadcastingplus-9_7-on-doubled-revenues-healthy-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3408701-huya-broadcastingplus-9_7-on-doubled-revenues-healthy-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408697\" data-ts=\"1542063339\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408697-yyplus-3_6-live-streaming-gains-pace-q3-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY +3.6% as live streaming gains pace Q3 beat</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color=\"green\">up 3.6%</font> after hours following a beat on top and bottom lines in its Q3 earnings, mainly driven by live streaming revenues.</li>    <li>Revenues grew by nearly a third and attributable net income rose almost 20%, to 787M yuan (about $114.6M).</li>    <li>Mobile live streaming monthly active users rose 20.7%, with total live streaming paying users up 26.3%.</li>    <li>Cash and equivalents were 4.92B yuan (about $716.5M) and short-term deposits came to 8.3B yuan (about $1.21B). Net cash from operations for the quarter was 822.4M yuan (about $119.7M).</li>    <li>For Q4, it's guiding to revenues of 4.39B-4.54B yuan (about $630M-$652M, and Y/Y growth of 21.1% to 25.2% in renminbi terms).</li>    <li>\n<a href=\"http://ir.yy.com/\" target=\"_blank\">Conference call</a> to come at 9 p.m. ET.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408688-yy-beats-0_06-beats-revenue\" target=\"_blank\">YY beats by $0.06, beats on revenue</a> (Nov. 12 2018)</li>    <li><a href=\"https://seekingalpha.com/pr/17330833-yy-reports-third-quarter-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3408697\" data-linked=\"YY +3.6% as live streaming gains pace Q3 beat\" data-tweet=\"$YY - YY +3.6% as live streaming gains pace Q3 beat https://seekingalpha.com/news/3408697-yyplus-3_6-live-streaming-gains-pace-q3-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3408697-yyplus-3_6-live-streaming-gains-pace-q3-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408690\" data-ts=\"1542062545\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XOG\" target=\"_blank\">XOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408690-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul> <li>\n<b>Top Gainers:</b> <a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas'>XOG</a> <font color=\"green\">+3.7%</font>. <a href='https://seekingalpha.com/symbol/HBM' title='Hudbay Minerals Inc Ordinary Sh'>HBM</a> <font color=\"green\">+2.6%</font>. <a href='https://seekingalpha.com/symbol/PCMI' title='PCM, Inc.'>PCMI</a> <font color=\"green\">+2.3%</font>. <a href='https://seekingalpha.com/symbol/CSTM' title='Constellium Holdco B.V.'>CSTM</a> <font color=\"green\">+2.1%</font>.</li> <li>\n<b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/EB' title='Eventbrite'>EB</a> <font color=\"red\">-8.5%</font>. <a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color=\"red\">-3.0%</font>. <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color=\"red\">-2.9%</font>.<a href='https://seekingalpha.com/symbol/CTT' title='CatchMark Timber Trust, Inc.'>CTT</a> <font color=\"red\">-2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408690\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$XOG $XOG $HBM - After Hours Gainers / Losers https://seekingalpha.com/news/3408690-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408690-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408687\" data-ts=\"1542061957\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408687-sage-therapeutics-gets-bear-shares-down-2_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sage Therapeutics gets a bear; shares down 2.3%</a></h4><ul>\n<li>Leerink's Marc Goodman initiates coverage on Sage Therapeutics with an Underperform rating and $80 price target, or about <font color=\"red\">33% downside</font> from this afternoon's close.</li>\n<li>Though Zulresso should be approved by year-end, Goodman expects a slow launch and believes the drug will prove to be just a \"niche product.\"</li>\n<li>Sage previously had 15 Buys, zero holds, and zero sells.</li>\n<li>Source: Bloomberg</li>\n<li>Shares <font color=\"red\">fell 7.25%</font> in today's regular session, and are <font color=\"red\">off another 2.35%</font> after hours to $118.60.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408687\" data-linked=\"Sage Therapeutics gets a bear; shares down 2.3%\" data-tweet=\"Sage Therapeutics gets a bear; shares down 2.3% https://seekingalpha.com/news/3408687-sage-therapeutics-gets-bear-shares-down-2_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3408687-sage-therapeutics-gets-bear-shares-down-2_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408679\" data-ts=\"1542061167\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YRD\" target=\"_blank\">YRD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408679-yirendaiminus-2_8-after-q3-revenue-misses-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yirendai -2.8% after Q3 revenue misses consensus</a></h4><ul>\n<li>Yirendai (NYSE:<a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a>)<font color=\"red\"> falls 2.8% </font>in after-hours trading after<a href=\"https://seekingalpha.com/pr/17330807-yirendai-reports-third-quarter-2018-financial-results\" target=\"_blank\"> Q3 revenue of $163.2M </a>misses consensus estimate by $26.7M.</li>\n<li>Q3 adjusted income per ADS of 86 cents.</li>\n<li>Amount of loans facilitated in Q3 fell 46% to RMB 6.55B ($941M) from RMB 12.2B a year ago.</li>\n<li>Q3 adjusted EBITDA rises 21% to RMB 509.3M from RMB 422.4M.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408671-yirendai-eps-0_86\" target=\"_blank\">Yirendai EPS of $0.86</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408679\" data-linked=\"Yirendai -2.8% after Q3 revenue misses consensus\" data-tweet=\"$YRD - Yirendai -2.8% after Q3 revenue misses consensus https://seekingalpha.com/news/3408679-yirendaiminus-2_8-after-q3-revenue-misses-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3408679-yirendaiminus-2_8-after-q3-revenue-misses-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408664\" data-ts=\"1542059555\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LITE\" target=\"_blank\">LITE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408664-lumentum-comments-on-order-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lumentum comments on that order cut</a></h4><ul> <li>Lumentum (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) presented at the UBS Conference today after cutting guidance this morning. The company says it got the order cut notification from its lead customer a few days ago.</li> <li>Lumentum didn\u2019t name the customer, but it\u2019s widely speculated to be Apple.</li> <li>The order cut was relatively large but the company isn't sure if it was due to softer demand, inventory build, or overproduction. LITE doesn\u2019t think there was a market share shift, but the customer doesn\u2019t share end-demand data.</li> <li>LITE is shipping $10M of 3D sensing for Android each quarter and, while unsure of the timeline, believes it will ramp to $40M to $50M per quarter.</li> <li>Lumentum says it has great business margins and \u201csolid\u201d cash flow.</li> <li>The Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) acquisition awaits Chinese regulatory approval, which has a March deadline. The deal is making progress, and Lumentum might look for additional deals.</li> <li>Source: Briefing.com.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408439-lumentum-drops-q2-guide-shipment-cut\" target=\"_blank\">Lumentum drops Q2 guide on shipment cut</a> (Nov. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408664\" data-linked=\"Lumentum comments on that order cut\" data-tweet=\"$LITE $LITE $OCLR - Lumentum comments on that order cut https://seekingalpha.com/news/3408664-lumentum-comments-on-order-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3408664-lumentum-comments-on-order-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408652\" data-ts=\"1542058637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408652-microchipplus-1-on-bmo-initiation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microchip +1% on BMO initiation</a></h4><ul>\n<li>        BMO<a href=\"https://www.streetinsider.com/New+Coverage/BMO+Capital+Starts+Microchip+Technology+%28MCHP%29+at+Outperform/14815575.html\" target=\"_blank\"> initiates</a> Microchip (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) with an Outperform rating and $92 price target.</li>\n<li>               Microchip reported Q2 beats with downside guidance last week and took a hit today as Apple suppliers fell after Lumentum\u2019s cut guidance. </li>\n<li>               Microchip shares closed today <font color=\"red\">down 3.4%</font> but are<font color=\"green\"> up 1.1%</font> aftermarket to $70.41.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408522-apple-suppliers-drop-lumentum-guide-iphone-target-cuts\" target=\"_blank\">Apple suppliers drop on Lumentum guide, iPhone target cuts</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408652\" data-linked=\"Microchip +1% on BMO initiation\" data-tweet=\"$MCHP - Microchip +1% on BMO initiation https://seekingalpha.com/news/3408652-microchipplus-1-on-bmo-initiation?source=tweet\" data-url=\"https://seekingalpha.com/news/3408652-microchipplus-1-on-bmo-initiation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408635\" data-ts=\"1542057637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOCS\" target=\"_blank\">FOCS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408635-focus-financial-partners-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Focus Financial Partners EPS in-line, misses on revenue</a></h4><ul>\n<li>Focus Financial Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/FOCS' title='Focus Financial Partners'>FOCS</a>): Q3 Non-GAAP EPS of $0.46 in-line; GAAP EPS of -$0.24 <span style=\"color:red\">misses by $0.21</span>.</li>\n<li>Revenue of $235.7M (+30.8% Y/Y) <font color=\"red\">misses by $4.31M</font>.</li>\n<li>Shares <font color=\"green\">+2.74%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17330748-focus-financial-partners-reports-third-quarter-2018-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408635\" data-linked=\"Focus Financial Partners EPS in-line, misses on revenue\" data-tweet=\"$FOCS - Focus Financial Partners EPS in-line, misses on revenue https://seekingalpha.com/news/3408635-focus-financial-partners-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3408635-focus-financial-partners-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408627\" data-ts=\"1542057186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTEK\" target=\"_blank\">FTEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408627-fuel-tech-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fuel Tech reports Q3 results</a></h4><ul>\n<li>Fuel Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/FTEK' title='Fuel Tech, Inc.'>FTEK</a>): Q3 GAAP EPS of $0.04.</li>\n<li>Revenue of $16.07M (+18.6% Y/Y)</li>\n<li>Shares <font color=\"green\">+11.64%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17330730-fuel-tech-reports-2018-third-quarter-financial-results\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408627\" data-linked=\"Fuel Tech reports Q3 results\" data-tweet=\"$FTEK - Fuel Tech reports Q3 results https://seekingalpha.com/news/3408627-fuel-tech-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3408627-fuel-tech-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408621\" data-ts=\"1542057055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHLD\" target=\"_blank\">MHLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408621-maiden-holdings-plunges-30-after-big-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maiden Holdings plunges 30%+ after big loss</a></h4><ul>\n<li>The company after the close on Friday announced a big $2.38 per share loss for Q3. Included was an adverse loss development of $210.4M in the AmTrust reinsurance segment vs. $61.1M a year earlier. The company agreed to a loss portfolio transfer of $2.675B of reinsurance contracts with AmTrust to Enstar, resulting in a charge of $74.2M for the write-off of goodwill and intangible assets.</li>\n<li>Insurance Insider reports Catalina as no longer interested in bidding for the company.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408319-maiden-holdings-eps-2_83\" target=\"_blank\">Maiden Holdings EPS of -$2.83</a> (Nov. 9)</li>\n<li><a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a> <font color=\"red\">-31.8%</font> for the session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408621\" data-linked=\"Maiden Holdings plunges 30%+ after big loss\" data-tweet=\"$MHLD - Maiden Holdings plunges 30%+ after big loss https://seekingalpha.com/news/3408621-maiden-holdings-plunges-30-after-big-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3408621-maiden-holdings-plunges-30-after-big-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408617\" data-ts=\"1542056970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLBS\" target=\"_blank\">GLBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408617-globus-maritime-reports-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globus Maritime reports Q3 results</a></h4><ul>\n<li>Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a>): Q3 GAAP EPS of $0.08.</li>\n<li>Revenue of $4.86M (+26.6% Y/Y)</li>\n<li>Shares <font color=\"green\">+7.13%</font>.</li>\n<li><a href=\"https://seekingalpha.com/pr/17330721-globus-maritime-limited-reports-financial-results-quarter-nine-month-period-ended-september\">Press Release</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408617\" data-linked=\"Globus Maritime reports Q3 results\" data-tweet=\"$GLBS - Globus Maritime reports Q3 results https://seekingalpha.com/news/3408617-globus-maritime-reports-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3408617-globus-maritime-reports-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408610\" data-ts=\"1542056222\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408610-report-california-regulators-investigating-pg-and-e-edison-over-roles-in-fires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: California regulators investigating PG&amp;E, Edison over roles in fires</a></h4><ul>\n<li>California regulators have <a href=\"https://www.mercurynews.com/2018/11/12/state-regulators-investigating-pge-socal-edison-for-roles-in-deadly-camp-woolsey-fires/\" target=\"_blank\">launched probes</a> into PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-17.4%</font>) and Southern California Edison (<a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color='red'>-12.2%</font>) after both companies reported that their electrical infrastructure suffered malfunctions near ground zero of the two giant wildfires currently <a href=\"https://seekingalpha.com/news/3408450-pg-and-e-minus-12-percent-edison-minus-6_5-percent-california-wildfires-rage\" target=\"_blank\">raging across the state</a>, the <em>San Jose Mercury News</em> reports.</li>\n<li>The California Public Utilities Commission says it launched investigations to \"assess the compliance of electric facilities with applicable rules and regulations in fire impacted areas.\"</li>\n<li>PG&amp;E disclosed to the CPUC that it had detected an  outage on a transmission line in Butte County, occurring ~15  minutes before the Camp Fire was first reported and in the same location  Cal Fire pinpointed as the origin, according to the report..</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408610\" data-linked=\"Report: California regulators investigating PG&amp;E, Edison over roles in fires\" data-tweet=\"$PCG $PCG $EIX - Report: California regulators investigating PG&amp;E, Edison over roles in fires https://seekingalpha.com/news/3408610-report-california-regulators-investigating-pg-and-e-edison-over-roles-in-fires?source=tweet\" data-url=\"https://seekingalpha.com/news/3408610-report-california-regulators-investigating-pg-and-e-edison-over-roles-in-fires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408609\" data-ts=\"1542056179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASUR\" target=\"_blank\">ASUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408609-needham-lowers-asure-target-on-short-term-pains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham lowers Asure target on short-term pains</a></h4><ul>\n<li>        Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Asure+Software+%28ASUR%29+PT+Lowered+to+%2412+at+Needham+%26+Company/14814665.html\" target=\"_blank\">lowers</a> its Asure Software (NASDAQ:<a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a>) target from $20 to $12 and maintains a Buy rating.</li>\n<li>               Analyst Scott Berg says that the Q3 results last week were \u201cclearly disappointing\u201d but \u201cFriday\u2019s sell-off drove ASUR\u2019s valuation far too low on what we see as short-term issues with a new HaaS model.\u201d </li>\n<li>               The analyst expects Asure shares to sit in the \u201cpenalty box\u201d until Q4 results but sees shares working higher through FY19. </li>\n<li>               Asure Software shares are <font color=\"red\">down 7.9%</font> to $7.14 on a rough day for the tech sector.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3407985-asure-software-misses-0_02-misses-revenue\" target=\"_blank\">Asure Software misses by $0.02, misses on revenue</a> (Nov. 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408609\" data-linked=\"Needham lowers Asure target on short-term pains\" data-tweet=\"$ASUR - Needham lowers Asure target on short-term pains https://seekingalpha.com/news/3408609-needham-lowers-asure-target-on-short-term-pains?source=tweet\" data-url=\"https://seekingalpha.com/news/3408609-needham-lowers-asure-target-on-short-term-pains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408608\" data-ts=\"1542056103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSMX\" target=\"_blank\">BSMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408608-mexican-stocks-sink-after-ruling-party-proposes-cutting-bank-fees\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mexican stocks sink after ruling party proposes cutting bank fees</a></h4><ul> <li>Banco Santander México (NYSE:<a href='https://seekingalpha.com/symbol/BSMX' title='Grupo Financiero Santander S.A.B. de C.V.'>BSMX</a>)<font color=\"red\"> slumps 4.8%</font> as Mexican stocks overall decline after the nation's ruling party said it will proceed with proposals to reduce bank fees.</li> <li>Senate members of the Morena party are pushing ahead with the proposals, after President-elect Andres Manual Lopez Obrador said on Friday that there would be no changes to banking laws soon.</li> <li>iShares MSCI Mexico Capped ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>) <font color=\"red\">dips 3.0% </font>in late trading in New York. Another Mexican bank Grupo Financiero Banorte <font color=\"red\">falls 1.5%</font>.</li>\n<li>Mexican peso <font color=\"red\">loses 0.8%</font> against the dollar.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3403465-banco-santander-mexico-falls-3_4-percent-q3-eps-slips-q2\" target=\"_blank\">Banco Santander México falls 3.4% after Q3 EPS slips from Q2</a> (Oct. 31)</li>\n<li>ETFs: <a href='https://seekingalpha.com/symbol/EWW' title='iShares MSCI Mexico Capped ETF'>EWW</a>, <a href='https://seekingalpha.com/symbol/MXF' title='Mexico Fund'>MXF</a>, <a href='https://seekingalpha.com/symbol/MXE' title='Mexico Equity&Income Fund'>MXE</a>, <a href='https://seekingalpha.com/symbol/DBMX' title='Deutsche X-trackers MSCI Mexico Hedged Equity ETF'>DBMX</a>, <a href='https://seekingalpha.com/symbol/HEWW' title='iShares Currency Hedged MSCI Mexico ETF'>HEWW</a>, <a href='https://seekingalpha.com/symbol/MEXX' title='Direxion Daily MSCI Mexico Bull 3X ETF'>MEXX</a>, <a href='https://seekingalpha.com/symbol/FLMX' title='Franklin FTSE Mexico ETF'>FLMX</a></li> <li>Related Stocks: <a href='https://seekingalpha.com/symbol/CX' title='Cemex, S.A.B. de C.V.'>CX</a>, <a href='https://seekingalpha.com/symbol/AMX' title='America Movil SA de CV'>AMX</a>, <a href='https://seekingalpha.com/symbol/KOF' title='Coca-Cola FEMSA, S.A.B. De C.V.'>KOF</a>, <a href='https://seekingalpha.com/symbol/PAC' title='Grupo Aeroportuario del Pacifico, S.A.B de C.V.'>PAC</a>, <a href='https://seekingalpha.com/symbol/VLRS' title='Volaris Aviation'>VLRS</a>, <a href='https://seekingalpha.com/symbol/FMX' title='Fomento Economico Mexicano, S.A.B. De C.V.'>FMX</a>, <a href='https://seekingalpha.com/symbol/TV' title='Grupo Televisa, S.A.'>TV</a>, <a href='https://seekingalpha.com/symbol/BSMX' title='Grupo Financiero Santander S.A.B. de C.V.'>BSMX</a>, <a href='https://seekingalpha.com/symbol/OMAB' title='Grupo Aeroportuario del Centro Norte S.A.B. de C.V.'>OMAB</a>, <a href='https://seekingalpha.com/symbol/ASR' title='Grupo Aeroportuario del Sureste, S.A.B. de C.V.'>ASR</a>, <a href='https://seekingalpha.com/symbol/WMMVY' title='Wal-Mart De Mexico S.A.B. de C.V. ADR'>OTCQX:WMMVY</a>, <a href='https://seekingalpha.com/symbol/GRBMF' title='Grupo Bimbo S.A.A'>OTCPK:GRBMF</a>, <a href='https://seekingalpha.com/symbol/IBA' title='Industrias Bachoco, S.A.B. de C.V.'>IBA</a>, <a href='https://seekingalpha.com/symbol/AMOV' title='America Movil, S.A.B. de C.V.'>AMOV</a>, <a href='https://seekingalpha.com/symbol/COCSF' title='Coca-Cola FEMSA S.A.B de CV'>OTCPK:COCSF</a>,</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408608\" data-linked=\"Mexican stocks sink after ruling party proposes cutting bank fees\" data-tweet=\"$BSMX $BSMX $EWW - Mexican stocks sink after ruling party proposes cutting bank fees https://seekingalpha.com/news/3408608-mexican-stocks-sink-after-ruling-party-proposes-cutting-bank-fees?source=tweet\" data-url=\"https://seekingalpha.com/news/3408608-mexican-stocks-sink-after-ruling-party-proposes-cutting-bank-fees\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408607\" data-ts=\"1542056087\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408607-stocks-near-session-lows-close\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks near session lows into the close</a></h4><ul><li>A few minutes before the final bell the Nasdaq is <font color=\"red\">down 2.7%</font>, the S&amp;P 500 <font color=\"red\">1.9%</font>, and DJIA <font color=\"red\">2.3%</font>. Names like Goldman Sachs, GE, and Apple are <font color=\"red\">down from 5-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3408607\" data-linked=\"Stocks near session lows into the close\" data-tweet=\"Stocks near session lows into the close https://seekingalpha.com/news/3408607-stocks-near-session-lows-close?source=tweet\" data-url=\"https://seekingalpha.com/news/3408607-stocks-near-session-lows-close\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408606\" data-ts=\"1542055989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABEO\" target=\"_blank\">ABEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408606-abeona-down-17-on-delay-of-late-stage-study-of-ebminus-101-in-rdeb\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abeona down 17% on delay of late-stage study of EB-101 in RDEB</a></h4><ul> <li>Abeona Therapeutics (<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a> <font color=\"red\">-17.1%</font>) is down on 70% higher volume in apparent response to an <a href=\"https://seekingalpha.com/article/4221400-abeona-therapeutics-inc-abeo-ceo-carsten-thiel-q3-2018-results-earnings-call-transcript?page=4\" target=\"_blank\">extended timeline</a> for the start of a Phase 3 clinical trial evaluating autologous cell therapy EB-101 in patients with recessive dystrophic epidermolysis bullosa &#40;RDEB&#41;, the most severe type of EB.</li> <li>Management had said that the study would launch in the second half of this year but now expects it to start in 2019 while CMC work and comparability studies are completed.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408606\" data-linked=\"Abeona down 17% on delay of late-stage study of EB-101 in RDEB\" data-tweet=\"$ABEO - Abeona down 17% on delay of late-stage study of EB-101 in RDEB https://seekingalpha.com/news/3408606-abeona-down-17-on-delay-of-late-stage-study-of-ebminus-101-in-rdeb?source=tweet\" data-url=\"https://seekingalpha.com/news/3408606-abeona-down-17-on-delay-of-late-stage-study-of-ebminus-101-in-rdeb\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408603\" data-ts=\"1542055195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408603-instinet-raises-amazon-target-over-2000\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instinet raises Amazon target over $2,000</a></h4><ul>\n<li>        Instinet <a href=\"https://www.marketwatch.com/story/amazons-stock-price-target-raised-above-2000-at-instinet-but-shares-fall-2018-11-12\" target=\"_blank\">raises</a> its Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) target from $1,990 to $2,050, a 20% upside to Friday\u2019s close.</li>\n<li>               Analyst Simeon Siegel says Amazon\u2019s margins are benefitting as the company becomes more of a mall than a retailer. </li>\n<li>               Rating reiterated at Buy. </li>\n<li>               Amazon is dropping with the rest of the tech sector with shares <font color=\"red\">down 4%</font> to $1,643.54.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408545-tech-lunch-break-apple-supplier-woes-sink-sector\" target=\"_blank\">Tech lunch break: Apple supplier woes sink sector</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408603\" data-linked=\"Instinet raises Amazon target over $2,000\" data-tweet=\"$AMZN - Instinet raises Amazon target over $2,000 https://seekingalpha.com/news/3408603-instinet-raises-amazon-target-over-2000?source=tweet\" data-url=\"https://seekingalpha.com/news/3408603-instinet-raises-amazon-target-over-2000\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408602\" data-ts=\"1542055101\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLTH\" target=\"_blank\">HLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408602-nobilis-down-30-on-10-q-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nobilis down 30% on 10-Q delay</a></h4><ul> <li>Thinly traded nano cap Nobilis Health (<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color=\"red\">-30%</font>) is down on a 5x surge in volume following its <a href=\"https://seekingalpha.com/pr/17329569-nobilis-health-announces-filing-form-12bminus-25\" target=\"_blank\">disclosure </a>that it will need additional time to complete its 10-Q for the quarter ended September 30.</li> <li>It says it is making a \"significant adjustment\" to the carrying value of accounts receivable, primarily out-of-network claims more than a year old.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408602\" data-linked=\"Nobilis down 30% on 10-Q delay\" data-tweet=\"$HLTH - Nobilis down 30% on 10-Q delay https://seekingalpha.com/news/3408602-nobilis-down-30-on-10-q-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3408602-nobilis-down-30-on-10-q-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408600\" data-ts=\"1542053907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTB\" target=\"_blank\">CTB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408600-cooper-tire-rubberplus-3-after-wolfe-research-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cooper Tire &amp; Rubber +3% after Wolfe Research lift</a></h4><ul> <li>Shares of Cooper Tire &amp; Rubber (NYSE:<a href='https://seekingalpha.com/symbol/CTB' title='Cooper Tire & Rubber Co.'>CTB</a>) are <font color=\"green\">up 3.2%</font> after Wolfe Research upgrades the tire stock to Peer Perform from Underperform.</li> <li>Wolfe on Cooper: \"CTB had been experiencing significant pressure on market share and margins over the prior 2 years. They\u2019re on track to generate relatively low free cash flow this year (close to breakeven). And we\u2019ve been concerned about longer term structural headwinds, including over-exposure to declining segments and declining distribution channels within the North American Tire market (&lt;17\u201d tires account for 56% of CTB\u2019s U.S. mix; this segment is expected to decline by 6-7% per year).\"</li> <li>Shares of Cooper Tire &amp; Rubber have been in an uptrend since the company reported earnings on October 29.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3401975-cooper-tire-and-rubbers-q3-results\" target=\"_blank\">More on Cooper Tire &amp; Rubber's Q3 results</a> (Oct. 29)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3401968-cooper-tire-and-rubber-beats-0_60-misses-revenue\" target=\"_blank\">Cooper Tire &amp; Rubber beats by $0.60, misses on revenue</a> (Oct. 29)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408600\" data-linked=\"Cooper Tire &amp; Rubber +3% after Wolfe Research lift\" data-tweet=\"$CTB - Cooper Tire &amp; Rubber +3% after Wolfe Research lift https://seekingalpha.com/news/3408600-cooper-tire-rubberplus-3-after-wolfe-research-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3408600-cooper-tire-rubberplus-3-after-wolfe-research-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408598\" data-ts=\"1542053652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSTI\" target=\"_blank\">BSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408598-bestplus-16_2-on-price-target-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Best +16.2% on price target cut</a></h4><ul>\n<li>        KeyBanc <a href=\"https://www.streetinsider.com/Analyst+Comments/BEST+Inc.+%28BSTI%29+PT+Lowered+to+%248+at+KeyBanc+Following+3Q/14814007.html\" target=\"_blank\">lowers</a> its Best (NYSE:<a href='https://seekingalpha.com/symbol/BSTI' title='Best, Inc.'>BSTI</a>) price target from $11 to $8, a 54% upside to Friday\u2019s close.</li>\n<li>               Rating maintained at Overweight. </li>\n<li>               Best reported Q3 revenue and EPS beats last week, but the Q4 revenue guidance was below the consensus estimates at the midpoint. </li>\n<li>               Best shares are <font color=\"green\">up 16.2% </font>to $6.05.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3407946-best-beats-0_05-beats-revenue\" target=\"_blank\">BEST beats by $0.05, beats on revenue</a> (Nov. 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408598\" data-linked=\"Best +16.2% on price target cut\" data-tweet=\"$BSTI $BEST - Best +16.2% on price target cut https://seekingalpha.com/news/3408598-bestplus-16_2-on-price-target-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3408598-bestplus-16_2-on-price-target-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408595\" data-ts=\"1542053022\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMO\" target=\"_blank\">IMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408595-imperial-oil-upgraded-barclays-after-reaching-inflection-point\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperial Oil upgraded at Barclays after reaching &#39;inflection point&#39;</a></h4><ul>\n<li>Imperial Oil (<a href='https://seekingalpha.com/symbol/IMO' title='Imperial Oil Ltd'>IMO</a> <font color='green'>+1.8%</font>) is higher after Barclays <a href=\"https://www.streetinsider.com/Analyst+Comments/Barclays+Upgrades+Imperial+Oil+Ltd.+%28IMO%3ACN%29+%28IMO%29+to+Overweight/14813535.html\" target=\"_blank\">upgrades</a> shares to Overweight from Equal Weight, saying the company has reached an \"important inflection point\" of improving operating and financial momentum.</li>\n<li>Barclays believes strong downstream and logistics operations will shield IMO from the current punishing differentials and actually will prove a net beneficiary in light of the current wide Canada light oil discount.</li>\n<li>In addition to IMO's strong near-term operational and financial momentum, the firm think the company's investment in the Kearl debottleneck projects and Aspen Phase 1 should generate  attractive returns upon completion.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408595\" data-linked=\"Imperial Oil upgraded at Barclays after reaching &#39;inflection point&#39;\" data-tweet=\"$IMO - Imperial Oil upgraded at Barclays after reaching &#39;inflection point&#39; https://seekingalpha.com/news/3408595-imperial-oil-upgraded-barclays-after-reaching-inflection-point?source=tweet\" data-url=\"https://seekingalpha.com/news/3408595-imperial-oil-upgraded-barclays-after-reaching-inflection-point\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408591\" data-ts=\"1542052537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSNT\" target=\"_blank\">SSNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408591-yelp-universal-display-oclaro-and-surveymonkey-among-notable-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp, Universal Display, Oclaro and SurveyMonkey among notable tech movers</a></h4><ul>\n<li>\n<strong>Gainers: </strong>SilverSun Technologies, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNT' title='SilverSun Technologies, Inc.'>SSNT</a>) <font color=\"green\">+25%</font>. BEST (NYSE:<a href='https://seekingalpha.com/symbol/BSTI' title='Best, Inc.'>BSTI</a>) <font color=\"green\">+16%</font>. athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) <font color=\"green\">+10%</font>. SVMK (NASDAQ:<a href='https://seekingalpha.com/symbol/SVMK' title='SurveyMonkey'>SVMK</a>) <font color=\"green\">+8%</font>. Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) <font color=\"green\">+7%</font>.</li> <li>\n<strong>Losers: </strong>Lumentum Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) <font color=\"red\">-32%</font>. II-VI Incorporated (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>) <font color=\"red\">-13%</font>. Universal Display (NASDAQ:<a href='https://seekingalpha.com/symbol/OLED' title='Universal Display Corporation'>OLED</a>) <font color=\"red\">-13%</font>. Unisys (NYSE:<a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a>) <font color=\"red\">-12%</font>. Oclaro (NASDAQ:<a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408591\" data-linked=\"Yelp, Universal Display, Oclaro and SurveyMonkey among notable tech movers\" data-tweet=\"$SSNT $SSNT $BEST - Yelp, Universal Display, Oclaro and SurveyMonkey among notable tech movers https://seekingalpha.com/news/3408591-yelp-universal-display-oclaro-and-surveymonkey-among-notable-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408591-yelp-universal-display-oclaro-and-surveymonkey-among-notable-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408590\" data-ts=\"1542052142\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408590-arcelormittal-says-one-month-needed-to-restore-kazakh-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal says one month needed to restore Kazakh production</a></h4><ul>\n<li>ArcelorMittal's (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-2.6%</font>) Kazakh unit says it expects to <a href=\"http://www.mining.com/web/arcelormittal-needs-one-month-restore-kazakh-output/\" target=\"_blank\">take a month to restore production</a> at its steel mill after an incident this weekend caused a partial suspension of operations.</li>\n<li>ArcelorMittal Temirtau, Kazakhstan's biggest steel mill, says several gas pipelines were damaged after a fire broke out at the plant.</li>\n<li>The unit nevertheless maintains guidance for production of 3.915M metric tons of steel this year, the plant's executive director says.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408590\" data-linked=\"ArcelorMittal says one month needed to restore Kazakh production\" data-tweet=\"$MT - ArcelorMittal says one month needed to restore Kazakh production https://seekingalpha.com/news/3408590-arcelormittal-says-one-month-needed-to-restore-kazakh-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3408590-arcelormittal-says-one-month-needed-to-restore-kazakh-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408585\" data-ts=\"1542049721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKCA\" target=\"_blank\">AKCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408585-akcea-up-3-on-positive-akcea-apo-lrx-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Akcea up 3% on positive AKCEA-APO(a)-Lrx data</a></h4><ul> <li>Akcea Therapeutics (<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a> <font color=\"green\">+2.9%</font>) is up on below-average volume on the heels of its <a href=\"https://seekingalpha.com/pr/17329862-phase-2-results-akcea-apo-lrx-presented-late-breaking-clinical-trial-presentation-aha\" target=\"_blank\">announcement </a>of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03070782?intr=akcea-apo%28a%29-Lrx&amp;lead=akcea&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating antisense drug AKCEA-APO(a)-Lrx in patients with established cardiovascular disease &#40;CVD&#41; and elevated levels of lipoprotein(a), an inherited CVD risk factor. The data were presented at the AHA Scientific Sessions in Chicago.</li> <li>The study met the two co-primary endpoints and all secondary endpoints. In the treatment group, average lipoprotein(a) [Lp(a)] levels dropped 35 - 80% from baseline compared to a drop of 6% for control. The treatment effects were dose-dependent and statistically significant.</li> <li>About 98% of patients in the 20 mg weekly cohort and ~81% of those in the 60 mg/four weeks cohort achieved Lp(a) levels below the recommended threshold for CVD risk of less than 50 mg/dL.</li> <li>On the safety front, most adverse events were mild and involved injection site reactions (ISRs). There was one discontinuation due to an ISR.</li> <li>If collaboration partner Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-0.8%</font>) exercises its option to license the candidate after the end-of-Phase 2 meeting with the FDA, AKCA will receive a $150M milestone payment, half of which will go to Ionis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"red\">-4.3%</font>). NVS will be responsible for all future development and commercialization activities. AKCA retains the right to co-commercialize AKCEA-APO(a)-Lrx in selected markets subject to mutually acceptable terms and conditions.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408585\" data-linked=\"Akcea up 3% on positive AKCEA-APO(a)-Lrx data\" data-tweet=\"$AKCA $AKCA $NVS - Akcea up 3% on positive AKCEA-APO(a)-Lrx data https://seekingalpha.com/news/3408585-akcea-up-3-on-positive-akcea-apo-lrx-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3408585-akcea-up-3-on-positive-akcea-apo-lrx-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408584\" data-ts=\"1542049322\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408584-bernstein-sees-balance-risk-reward-on-michael-kors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bernstein sees balance risk-reward on Michael Kors</a></h4><ul>\n<li>Michael Kors (KORS <font color='green'>+1.8%</font>) tracks higher after <a href=\"https://www.barrons.com/articles/michael-kors-stock-rises-on-analyst-upgrade-1542039143\" target=\"_blank\">landing</a> an upgrade from Bernstein to a Market Perform rating from Underperform.</li>\n<li>The firm sees the risk-reward profile on MK as balanced at the current share price level, although it still calls a full brand turnaround \"elusive\" due to the ongoing margin pressure.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408584\" data-linked=\"Bernstein sees balance risk-reward on Michael Kors\" data-tweet=\"$CPRI - Bernstein sees balance risk-reward on Michael Kors https://seekingalpha.com/news/3408584-bernstein-sees-balance-risk-reward-on-michael-kors?source=tweet\" data-url=\"https://seekingalpha.com/news/3408584-bernstein-sees-balance-risk-reward-on-michael-kors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408583\" data-ts=\"1542049293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEU\" target=\"_blank\">LEU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408583-centrus-energy-leads-energy-materials-gainers-while-mountain-province-diamonds-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centrus Energy leads the Energy/Materials gainers, while Mountain Province Diamonds leads the losers</a></h4><ul>\n<li>\n<b>Gainers: </b>Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+14%</font>. Sanchez Energy (NYSE:<a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a>) <font color=\"green\">+11%</font>. FutureFuel (NYSE:<a href='https://seekingalpha.com/symbol/FF' title='FutureFuel Corp.'>FF</a>) <font color=\"green\">+8%</font>. VOC Energy Trust (NYSE:<a href='https://seekingalpha.com/symbol/VOC' title='VOC Energy Trust'>VOC</a>) <font color=\"green\">+5%</font>.</li>\n<li>\n<b>Losers: </b>Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-16%</font>. Superior Drilling Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a>) <font color=\"red\">-11%</font>. Extraction Oil &amp; Gas (NASDAQ:<a href='https://seekingalpha.com/symbol/XOG' title='Extraction Oil & Gas'>XOG</a>) <font color=\"red\">-11%</font>. Pershing Gold (NASDAQ:<a href='https://seekingalpha.com/symbol/PGLC' title='Pershing Gold Corporation'>PGLC</a>) <font color=\"red\">-10%</font>. Independence Contract Drilling (NYSE:<a href='https://seekingalpha.com/symbol/ICD' title='Independence Contract Drilling'>ICD</a>) <font color=\"red\">-9%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408583\" data-linked=\"Centrus Energy leads the Energy/Materials gainers, while Mountain Province Diamonds leads the losers\" data-tweet=\"$LEU $LEU $SNEC - Centrus Energy leads the Energy/Materials gainers, while Mountain Province Diamonds leads the losers https://seekingalpha.com/news/3408583-centrus-energy-leads-energy-materials-gainers-while-mountain-province-diamonds-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408583-centrus-energy-leads-energy-materials-gainers-while-mountain-province-diamonds-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408581\" data-ts=\"1542048885\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408581-instagram-spurred-citrons-left-to-cover-facebook-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Instagram spurred Citron&#39;s Left to cover Facebook short</a></h4><ul>   <li>Short-seller Andrew Left of Citron Research covered his short position on Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"red\">-2.4%</font>), Reuters reports, and it's all <a href=\"https://www.reuters.com/article/us-investment-summit-left-facebook/citrons-left-covered-facebook-short-still-bearish-on-netflix-idUSKCN1NH27M\" target=\"_blank\">due to the power of Instagram</a>.</li>    <li>\u201cInstagram has really become a powerhouse - you can no longer deny it,\u201d Left said at a Reuters summit, pointing to its insights into what people want to buy.</li>    <li>He's not short on most of the FAANGs now, noting it's hard to make money shorting Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color=\"red\">-2%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color=\"red\">-2.1%</font>) with its Google \"cash cow,\" and Amazon (<a href=\"http://seekingalpha.com/symbol/AMZN\" target=\"_blank\">AMZN</a> <font color=\"red\">-3.5%</font>), which benefits from continuing strength in online shopping.</li>    <li>He is still short Netflix (<a href=\"http://seekingalpha.com/symbol/NFLX\" target=\"_blank\">NFLX</a> <font color=\"red\">-2.6%</font>), though, since it's \"addicted to debt\" and beset with competition.</li>    <li>\u201cFacebook can do what Netflix does, but Netflix can\u2019t do what Facebook does,\u201d he said. \u201cYou can\u2019t think that the rest of Hollywood will throw its hands up and say, \u2018OK Netflix, you win.\u2019 \u201d</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408581\" data-linked=\"Instagram spurred Citron&#39;s Left to cover Facebook short\" data-tweet=\"$GOOG $GOOG $GOOGL - Instagram spurred Citron&#39;s Left to cover Facebook short https://seekingalpha.com/news/3408581-instagram-spurred-citrons-left-to-cover-facebook-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3408581-instagram-spurred-citrons-left-to-cover-facebook-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408579\" data-ts=\"1542048636\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408579-intel-accelerates-5g-modem-production\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel accelerates 5G modem production</a></h4><ul>\n<li>        Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-2.4%</font>) <a href=\"https://seekingalpha.com/pr/17330425-intel-accelerates-timing-intel-xmm-8160-5g-multimode-modem-support-broad-global-5g-rollouts\" target=\"_blank\">accelerates</a> production of its first 5G modem by more than six months with availability in 2H19.</li>\n<li>               Moving up production of the XMM 8160 chip allows Apple and other smartphone makers to test the chip before making the 5G-supporitng devices that will start hitting the market in 2020. </li>\n<li>               Rival Qualcomm (<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> <font color='red'>-3.3%</font>) has at <a href=\"https://www.theverge.com/2018/11/12/18087860/intel-5g-modem-apple-iphone\" target=\"_blank\">least 18 major companies</a> including Samsung and Xiaomi signed up for its Snapdragon X50 5G NR modems. Huawei and Samsung are also working on in-house 5G modems. </li>\n<li>               Apple switched to using Intel modems exclusively for this year\u2019s iPhone XS and XR models. The company reportedly plans to stick with Intel when making the jump to 5G models.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3313254-fast-company-apple-intel-working-together-5g-modem\" target=\"_blank\">Fast Company: Apple and Intel working together on 5G modem</a> (Nov. 17, 2017)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3328074-apple-supplier-optimistic-iphone-8-demand-intel-replacing-qualcomm-modems\" target=\"_blank\">Apple supplier optimistic on iPhone 8 demand; Intel replacing Qualcomm modems?</a> (Feb. 5)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408579\" data-linked=\"Intel accelerates 5G modem production\" data-tweet=\"$INTC $INTC $QCOM - Intel accelerates 5G modem production https://seekingalpha.com/news/3408579-intel-accelerates-5g-modem-production?source=tweet\" data-url=\"https://seekingalpha.com/news/3408579-intel-accelerates-5g-modem-production\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408576\" data-ts=\"1542048283\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BFR\" target=\"_blank\">BFR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408576-fitch-changes-7-argentine-fi-outlooks-to-negative\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fitch changes 7 Argentine FI outlooks to negative</a></h4><ul>\n<li>Fitch Ratings revises<a href=\"https://www.fitchratings.com/site/pr/10051697\" target=\"_blank\"> the ratings outlook </a>on seven Argentine financial institutions to negative from stable after changing the outlook on Argentina's sovereign rating last week.</li>\n<li>Among the banks are: Banco Santander Rio, BBVA Banco Frances (<a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.  ADR'>BFR</a> <font color='red'>-2.2%</font>), Banco Macro (<a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='red'>-1.8%</font>), and Banco Supervielle (<a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='red'>-1.7%</font>)</li>\n<li>Argentinian peso <font color=\"red\">weakens 0.5%</font> against the U.S. dollar; the dollar strengthens today amid political uncertainty in Europe, global trade concerns and expectations for higher U.S. interest rates.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3395522-currency-devaluation-slows-telecom-argentina-investment\" target=\"_blank\">Currency devaluation slows Telecom Argentina investment</a> (Oct. 5)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3393460-cash-imf-fails-stop-argentine-pesos-decline\" target=\"_blank\">More cash from the IMF fails to stop Argentine peso's decline</a> (Sept. 27)</li>\n<li>Related Stocks: <a href='https://seekingalpha.com/symbol/GGAL' title='Grupo Financiero Galicia S.A.'>GGAL</a>, <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a>, <a href='https://seekingalpha.com/symbol/IRS' title='IRSA Inversiones Y Representaciones S.A.'>IRS</a>, <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.  ADR'>BFR</a>, <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a>, <a href='https://seekingalpha.com/symbol/IRCP' title='IRSA Propiedades Comerciales S.A.'>IRCP</a>, <a href='https://seekingalpha.com/symbol/CRESF' title='Cresud SA Comercial Industrial Financiera  Y Agropecuria Cres'>OTC:CRESF</a>, <a href='https://seekingalpha.com/symbol/BHPTY' title='Banco Hipotecario S.A. ADR'>OTC:BHPTY</a>, <a href='https://seekingalpha.com/symbol/GGABF' title='Grupo Financiero Galicia S.A.B'>OTC:GGABF</a>, <a href='https://seekingalpha.com/symbol/TGLUY' title='TGLT S.A. ADR'>OTC:TGLUY</a>, <a href='https://seekingalpha.com/symbol/BPTGY' title='Banco Patagonia S.A. ADR'>OTC:BPTGY</a></li>\n<li>ETFs: <a href='https://seekingalpha.com/symbol/ARGT' title='Global X MSCI Argentina ETF'>ARGT</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408576\" data-linked=\"Fitch changes 7 Argentine FI outlooks to negative\" data-tweet=\"$BFR $BBAR $BMA - Fitch changes 7 Argentine FI outlooks to negative https://seekingalpha.com/news/3408576-fitch-changes-7-argentine-fi-outlooks-to-negative?source=tweet\" data-url=\"https://seekingalpha.com/news/3408576-fitch-changes-7-argentine-fi-outlooks-to-negative\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408575\" data-ts=\"1542048160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408575-oil-rally-fades-trump-weighs-in-on-saudis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oil rally fades further as Trump weighs in on Saudis</a></h4><ul>\n<li>Crude attempted to pull out of its bear run earlier today after <a href=\"https://seekingalpha.com/news/3408356-saudis-bolster-oil-prices-supply-cut\" target=\"_blank\">the Saudis promised to</a> slash oil exports. That's faded over the past couple of hours, with WTI crude now <font color=\"red\">modestly lower</font> on the session at $59.98 per barrel.</li>\n<li>Helping things along in the last few minutes has been the U.S. president, who <a href=\"https://twitter.com/realDonaldTrump/status/1062047641889095684\" target=\"_blank\">tweeted out his</a> request that Saudi Arabia and OPEC not cut production.</li>\n<li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/UHN' title='The United States Diesel-Heating Oil ETF, LP'>UHN</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a>, <a href='https://seekingalpha.com/symbol/WTIU' title='ProShares Daily 3x Long Crude ETN'>WTIU</a>, <a href='https://seekingalpha.com/symbol/OILK' title='ProShares K-1 Free Crude Oil Strategy ETF'>OILK</a>, <a href='https://seekingalpha.com/symbol/OILX' title='Etracs S&P GSCI Crude Oil Total Return Index ETN'>OILX</a>, <a href='https://seekingalpha.com/symbol/WTID' title='ProShares Daily 3x Inverse Crude ETN'>WTID</a>, <a href='https://seekingalpha.com/symbol/USOI' title='Credit Suisse Crude Oil Shares Covered Call ETN'>USOI</a>, <a href='https://seekingalpha.com/symbol/USOU' title='United States 3x Oil Fund'>USOU</a>, <a href='https://seekingalpha.com/symbol/USOD' title='United States 3x Short Oil Fund ETF'>USOD</a>, <a href='https://seekingalpha.com/symbol/OILD' title='ProShares UltraPro 3x Short Crude Oil ETF'>OILD</a>, <a href='https://seekingalpha.com/symbol/OILU' title='ProShares UltraPro 3x Crude Oil ETF'>OILU</a>, <a href='https://seekingalpha.com/symbol/USAI' title='American Energy Independence ETF'>USAI</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408575\" data-linked=\"Oil rally fades further as Trump weighs in on Saudis\" data-tweet=\"$USO $OIL $UWT - Oil rally fades further as Trump weighs in on Saudis https://seekingalpha.com/news/3408575-oil-rally-fades-trump-weighs-in-on-saudis?source=tweet\" data-url=\"https://seekingalpha.com/news/3408575-oil-rally-fades-trump-weighs-in-on-saudis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>123&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408573\" data-ts=\"1542047932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KALV\" target=\"_blank\">KALV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408573-kalvista-up-2-on-accelerated-development-plan-for-lead-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KalVista up 2% on accelerated development plan for lead candidate</a></h4><ul> <li>Thinly traded micro cap KalVista Pharmaceuticals (<a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a> <font color=\"green\">+2%</font>) is up, albeit on turnover of only 16K shares, on the heels of its more aggressive <a href=\"https://seekingalpha.com/pr/17329936-kalvista-pharmaceuticals-provides-clinical-update-kvd900\" target=\"_blank\">development plan</a> for lead candidate KVD900, an oral kallikrein inhibitor.</li> <li>The company plans to design a larger Phase 2 study (~50 subjects) assessing KVD900 as on-demand treatment for hereditary angioedema attacks &#40;HAE&#41; attacks, the results from which will support its talks with the FDA about an accelerated approval pathway. The study should launch this quarter with topline data expected in Q4 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408573\" data-linked=\"KalVista up 2% on accelerated development plan for lead candidate\" data-tweet=\"$KALV - KalVista up 2% on accelerated development plan for lead candidate https://seekingalpha.com/news/3408573-kalvista-up-2-on-accelerated-development-plan-for-lead-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3408573-kalvista-up-2-on-accelerated-development-plan-for-lead-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408572\" data-ts=\"1542047409\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408572-citrons-left-expects-canadian-cannabis-names-to-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citron&#39;s Left expects Canadian cannabis names to fall</a></h4><ul>\n<li>Citron Research's Andrew Left <a href=\"https://www.theglobeandmail.com/cannabis/article-citrons-andrew-left-bearish-on-canadian-cannabis-producers/\" target=\"_blank\">expects</a> Canadian cannabis stocks to blow up in the future.</li>\n<li>\"When U.S. LPs (companies) go public in the next few years it will make these Canadian companies laughable,\" Left says.</li>\n<li>\"The cannabis trade is a perfect trade because the cannabis trade is a nonbranded, no-moat megatrend,\" he adds.</li>\n<li>Left says he has kept his short position in Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+4.2%</font>) through the recent rally on the expectation that when the IPO lock-up expires the doubled float will force the share price down.</li>\n<li>Left has no position in Canopy Growth (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color='red'>-2%</font>).</li>\n<li>Related names: <a href='https://seekingalpha.com/symbol/MJNA' title='Medical Marijuana, Inc.'>OTCPK:MJNA</a>, <a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>, <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>, <a href='https://seekingalpha.com/symbol/PHOT' title='Growlife Inc.'>OTCQB:PHOT</a>, <a href='https://seekingalpha.com/symbol/CBIS' title='Cannabis Science, Inc.'>OTCPK:CBIS</a>, APHQF, <a href='https://seekingalpha.com/symbol/TRTC' title='Terra Tech Corp.'>OTCQX:TRTC</a>, <a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>, <a href='https://seekingalpha.com/symbol/CANN' title='General Cannabis Corp.'>OTCQX:CANN</a>, <a href='https://seekingalpha.com/symbol/ERBB' title='American Green, Inc.'>OTCPK:ERBB</a>, <a href='https://seekingalpha.com/symbol/GRNH' title='GreenGro Technologies, Inc.'>OTCPK:GRNH</a>, <a href='https://seekingalpha.com/symbol/PMCB' title='PharmaCyte Biotech, Inc.'>OTCQB:PMCB</a>, <a href='https://seekingalpha.com/symbol/CVSI' title='CV Sciences, Inc.'>OTCQB:CVSI</a>, <a href='https://seekingalpha.com/symbol/FITX' title='Creative Edge Nutrition, Inc.'>OTC:FITX</a>, <a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>, <a href='https://seekingalpha.com/symbol/HEMP' title='Hemp, Inc.'>OTCPK:HEMP</a>, <a href='https://seekingalpha.com/symbol/CBDS' title='Cannabis Sativa, Inc.'>OTCQB:CBDS</a>, <a href='https://seekingalpha.com/symbol/BLOZF' title='Cannabix Technologies Inc.'>OTCPK:BLOZF</a>, <a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a>, <a href='https://seekingalpha.com/symbol/MSRT' title='MassRoots, Inc.'>OTCQB:MSRT</a> <a href='https://seekingalpha.com/symbol/SPRWF' title='Supreme Cannabis Co Inc.'>OTCQX:SPRWF</a>, <a href='https://seekingalpha.com/symbol/AGTK' title='Agritek Holdings, Inc.'>OTCPK:AGTK</a>, <a href='https://seekingalpha.com/symbol/AMMJ' title='American Cannabis Company, Inc.'>OTCPK:AMMJ</a>, <a href='https://seekingalpha.com/symbol/VAPE' title='Vape Holdings, Inc.'>OTCPK:VAPE</a>, HYYDF, <a href='https://seekingalpha.com/symbol/GBLX' title='GB Sciences, Inc.'>OTCQB:GBLX</a>, <a href='https://seekingalpha.com/symbol/AERO' title='Aero Grow International, Inc.'>OTCQB:AERO</a>, <a href='https://seekingalpha.com/symbol/MCOA' title='Marijuana Company of America, Inc.'>OTCQB:MCOA</a>, <a href='https://seekingalpha.com/symbol/HMLSF' title='Horizons Marijuana Life Sciences Index ETF'>OTC:HMLSF</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3408572\" data-linked=\"Citron&#39;s Left expects Canadian cannabis names to fall\" data-tweet=\"$TLRY $TLRY $CGC - Citron&#39;s Left expects Canadian cannabis names to fall https://seekingalpha.com/news/3408572-citrons-left-expects-canadian-cannabis-names-to-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3408572-citrons-left-expects-canadian-cannabis-names-to-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408568\" data-ts=\"1542046517\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIDX\" target=\"_blank\">EIDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408568-eidos-up-14-on-positive-ag10-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eidos up 14% on positive AG10 data</a></h4><ul> <li>Thinly traded Eidos Therapeutics (<a href='https://seekingalpha.com/symbol/EIDX' title='Eidos Therapeutics'>EIDX</a> <font color=\"green\">+14.1%</font>) is up on more than triple normal volume following its <a href=\"https://seekingalpha.com/pr/17329686-eidos-therapeutics-announces-positive-phase-2-data-ag10-symptomatic-patients-mutant-wild-type\" target=\"_blank\">announcement </a>of positive results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03458130?intr=ag10&amp;lead=eidos+therapeutics&amp;phase=1&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> evaluating lead candidate AG10 in patients with symptomatic transthyretin &#40;TTR&#41; amyloidosis cardiomyopathy (ATTR-CM). The data were presented at the AHA Scientific Sessions in Chicago.</li> <li>The 49 enrolled patients had at least one prior heart failure hospitalization or were receiving active treatment for chronic heart failure. They were randomly assigned to receive either 400 mg or 800 mg of AG10 twice daily or placebo.</li> <li>The study met the primary endpoint of safety. AG10 was well-tolerated with no significant areas of concern observed. The overall rates of adverse events in the 400 mg, 800 mg and control arms were 63%, 69% and 88%, respectively.</li> <li>100% of the patients in the treatment arms achieved normalized serum TTR levels at day 28 compared to 31% for placebo.</li> <li>AG10 is an orally administered small molecule designed to stabilize TTR, a protein that transports the thyroid hormone thyroxine (T4). TTR misfolding and aggregation causes amyloidosis, the abnormal buildup of amyloid in the body.</li> <li>A Phase 3 study should launch in H1 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408568\" data-linked=\"Eidos up 14% on positive AG10 data\" data-tweet=\"$EIDX - Eidos up 14% on positive AG10 data https://seekingalpha.com/news/3408568-eidos-up-14-on-positive-ag10-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3408568-eidos-up-14-on-positive-ag10-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408566\" data-ts=\"1542046383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNHC\" target=\"_blank\">FNHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408566-fednat-holding-company-only-financial-gainer-while-maiden-holdings-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FedNat Holding Company the only financial gainer while Maiden Holdings leads losers</a></h4><ul>\n<li>\n<b>Gainers:</b> FedNat Holding Company (NASDAQ:<a href='https://seekingalpha.com/symbol/FNHC' title='FedNat Holding Company'>FNHC</a>) <font color=\"green\">+5%</font>.</li> <li>\n<b>Losers:</b> Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-29%</font>. Trupanion (NYSE:<a href='https://seekingalpha.com/symbol/TRUP' title='Trupanion'>TRUP</a>) <font color=\"red\">-9%</font>. MoneyGram International (NYSE:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"red\">-9%</font>. Plymouth Industrial REIT (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLYM' title='Plymouth Industrial REIT'>PLYM</a>) <font color=\"red\">-8%</font>. PagSeguro Digital (NYSE:<a href='https://seekingalpha.com/symbol/PAGS' title='PagSeguro Digital Ltd.'>PAGS</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408566\" data-linked=\"FedNat Holding Company the only financial gainer while Maiden Holdings leads losers\" data-tweet=\"$FNHC $FNHC $MHLD - FedNat Holding Company the only financial gainer while Maiden Holdings leads losers https://seekingalpha.com/news/3408566-fednat-holding-company-only-financial-gainer-while-maiden-holdings-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408566-fednat-holding-company-only-financial-gainer-while-maiden-holdings-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408567\" data-ts=\"1542046361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408567-snaps-content-vp-latest-to-exit-company-amid-reorg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap&#39;s content VP latest to exit company amid reorg</a></h4><ul>   <li>The exodus continues: Snap's (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color=\"red\">-2.7%</font>) VP of content is <a href=\"https://cheddar.com/videos/snap-vp-content-nick-bell-to-leave\" target=\"_blank\">exiting the company</a>, Cheddar reports, the latest in a series of executive exits as the company wrestles with stock performance and app redesigns.</li>    <li>Nick Bell will leave as part of a planned reorg of the company's content team, now reporting to new Chief Strategy Officer Jared Grusd, Cheddar says.</li>    <li>Bell joined the company in 2014 to lead the Discover section, but Grusd was installed a few weeks ago as a layer of management between Bell and CEO Evan Spiegel.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3400387-snap-hires-former-amazon-huffpo-execs-run-strategy\" target=\"_blank\">Snap hires former Amazon, HuffPo execs to run strategy</a> (Oct. 24 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408567\" data-linked=\"Snap&#39;s content VP latest to exit company amid reorg\" data-tweet=\"$SNAP - Snap&#39;s content VP latest to exit company amid reorg https://seekingalpha.com/news/3408567-snaps-content-vp-latest-to-exit-company-amid-reorg?source=tweet\" data-url=\"https://seekingalpha.com/news/3408567-snaps-content-vp-latest-to-exit-company-amid-reorg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408563\" data-ts=\"1542045252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDOR\" target=\"_blank\">CDOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408563-condor-hospitalityminus-4_5-after-suspending-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Condor Hospitality -4.5% after suspending guidance</a></h4><ul>\n<li>Condor Hospitality (NYSEMKT:<a href='https://seekingalpha.com/symbol/CDOR' title='Condor Hospitality Trust, Inc.'>CDOR</a>) <font color=\"red\">sinks 4.5%</font> after <a href=\"https://seekingalpha.com/pr/17329888-condor-hospitality-trust-reports-third-quarter-2018-results\" target=\"_blank\">suspending guidance</a> while it evaluates alternatives to enhance shareholder value.</li>\n<li>Also says it agreed to sell its last remaining legacy asset, Quality Inn Solomons Island, but can't guarantee the disposition will close.</li>\n<li>Q3 adjusted FFO per share of 18 cents declines from 28 cents in the year-ago quarter.</li>\n<li>Q3 revenue of $15.5M misses consensus estimate by $2.7M and slips from $15.6M a year ago.</li>\n<li>Q3 adjusted EBITDAre of $4.7M vs. $5.0M a year ago.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408386-condor-hospitality-misses-revenue\" target=\"_blank\">Condor Hospitality misses on revenue</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408563\" data-linked=\"Condor Hospitality -4.5% after suspending guidance\" data-tweet=\"$CDOR - Condor Hospitality -4.5% after suspending guidance https://seekingalpha.com/news/3408563-condor-hospitalityminus-4_5-after-suspending-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3408563-condor-hospitalityminus-4_5-after-suspending-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408553\" data-ts=\"1542044681\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDGL\" target=\"_blank\">MDGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408553-madrigal-pharma-up-3-on-positive-mid-stage-mglminus-3196-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Madrigal Pharma up 3% on positive mid-stage MGL-3196 data</a></h4><ul> <li>Thinly traded Madrigal Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color=\"green\">+2.5%</font>) is up, albeit on turnover of only 112K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17330485-phase-2-results-madrigal-s-mglminus-3196-non-alcoholic-steatohepatitis-nash-presented\" target=\"_blank\">announcement </a>of successful results from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02912260?intr=MGL-3196&amp;lead=madrigal+pharmaceuticals&amp;phase=1&amp;rank=2\" target=\"_blank\">Phase 2 clinical trial</a> evaluating MGL-3196 in NASH patients.</li> <li>The study met the primary endpoint of a statistically significant reduction in liver fat at week 12 compared to placebo. Specifically, patients receiving MGL-3196 showed a median 36.3% reduction in liver fat compared to a median of 9.6% for control.  The median reduction in liver fat was 42.0% in a pre-specified subgroup of high exposure MGL-3196-treated patients (p&lt;0.0001). 75% of the high exposure patients experienced reductions in liver fat of at least 30%.</li> <li>At week 36, patients in the treatment group showed sustained reductions of fibrosis biomarkers. Fibrosis was resolved in half of the patients with NASH resolution who received MGL-3196.</li> <li>In a separate <a href=\"https://clinicaltrials.gov/ct2/show/NCT03038022?intr=MGL-3196&amp;lead=madrigal+pharmaceuticals&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 study</a> in patients with heterozygous familial hypercholesterolemia (HeFH) not at their goals for \"bad cholesterol\" who received the optimal dose of MGL-3196 (in addition to their currently cholesterol-lowering therapies) experienced ~19 - 21% lowering of \"bad cholesterol\" compared to placebo. Treatment with MGL-3196 lowered \"bad cholesterol\" almost 29% in patients who could not tolerate high-intensity statins.</li> <li>\n<a href=\"http://www.madrigalpharma.com/home-page/pipeline/thr-beta-agonist/\" target=\"_blank\">MGL-3196</a> is a once-daily, orally available, liver-directed selective thyroid hormone receptor-beta agonist.</li>\n<li>Phase 3 studies are next up.</li> <li>Management will host a conference call this evening at 10:00 pm ET to discuss the results.</li> <li>Competitor Viking Therapeutics (<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color=\"red\">-4.1%</font>) is down on below-average volume.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3360612-madrigals-mglminus-3196-shows-sustained-benefit-mid-stage-nash-study-shares-40-percent\" target=\"_blank\">Madrigal's MGL-3196 shows sustained benefit in mid-stage NASH study; shares up 40% premarket</a> (May 31)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408553\" data-linked=\"Madrigal Pharma up 3% on positive mid-stage MGL-3196 data\" data-tweet=\"$MDGL $MDGL $VKTX - Madrigal Pharma up 3% on positive mid-stage MGL-3196 data https://seekingalpha.com/news/3408553-madrigal-pharma-up-3-on-positive-mid-stage-mglminus-3196-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3408553-madrigal-pharma-up-3-on-positive-mid-stage-mglminus-3196-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408559\" data-ts=\"1542044492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTI\" target=\"_blank\">APTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408559-healthcare-and-tech-tops-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare and Tech tops midday movers</a></h4><ul>\n<li>\n<strong>Gainers: </strong>Apptio (NASDAQ:<a href='https://seekingalpha.com/symbol/APTI' title='Apptio'>APTI</a>) <font color=\"green\">+51%</font>. OPKO Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) <font color=\"green\">+21%</font>. Globus Maritime (NASDAQ:<a href='https://seekingalpha.com/symbol/GLBS' title='Globus Maritime Ltd.'>GLBS</a>) <font color=\"green\">+20%</font>. Verrica Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/VRCA' title='Verrica Pharmaceuticals Inc.'>VRCA</a>) <font color=\"green\">+17%</font>. InnerWorkings (NASDAQ:<a href='https://seekingalpha.com/symbol/INWK' title='InnerWorkings, Inc.'>INWK</a>) <font color=\"green\">+16%</font>. BEST (NYSE:<a href='https://seekingalpha.com/symbol/BSTI' title='Best, Inc.'>BSTI</a>) <font color=\"green\">+16%</font>. Akers Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/AKER' title='Akers Biosciences Inc.'>AKER</a>) <font color=\"green\">+15%</font>. Eidos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/EIDX' title='Eidos Therapeutics'>EIDX</a>) <font color=\"green\">+14%</font>. Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+13%</font>. Caladrius Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLBS' title='Caladrius Biosciences, Inc.'>CLBS</a>) <font color=\"green\">+12%</font>.</li> <li>\n<strong>Losers: </strong>Infinity Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a>) <font color=\"red\">-34%</font>. Hudson Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/HDSN' title='Hudson Technologies, Inc.'>HDSN</a>) <font color=\"red\">-32%</font>. Lumentum Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/LITE' title='Lumentum Holdings Inc.'>LITE</a>) <font color=\"red\">-29%</font>. Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-27%</font>. Mesoblast (NASDAQ:<a href='https://seekingalpha.com/symbol/MESO' title='Mesoblast'>MESO</a>) <font color=\"red\">-26%</font>. Autolus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AUTL' title='Autolus Therapeutics'>AUTL</a>) <font color=\"red\">-23%</font>. Baozun (NASDAQ:<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun'>BZUN</a>) <font color=\"red\">-21%</font>. Matinas BioPharma Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/MTNB' title='Matinas Biopharma Holdings, Inc.'>MTNB</a>) <font color=\"red\">-20%</font>. Novelion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/NVLN' title='Novelion Therapeutics, Inc.'>NVLN</a>) <font color=\"red\">-20%</font>. GNC Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GNC' title='GNC Holdings, Inc.'>GNC</a>) <font color=\"red\">-18%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408559\" data-linked=\"Healthcare and Tech tops midday movers\" data-tweet=\"$APTI $APTI $OPK - Healthcare and Tech tops midday movers https://seekingalpha.com/news/3408559-healthcare-and-tech-tops-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408559-healthcare-and-tech-tops-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408558\" data-ts=\"1542043794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408558-ge-down-another-5-culp-comments-fail-to-reassure-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE down another 5% as Culp comments fail to reassure investors</a></h4><ul> <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color=\"red\">-5.2%</font>) extends its recent rout, tumbling to as low as $7.72 before rebounding somewhat after CEO Larry Culp\u2019s <a href=\"https://finance.yahoo.com/news/ge-ceo-says-debt-cut-144646873.html\" target=\"_blank\">attempt to reassure investors fell flat</a>.</li> <li>\"<a href=\"https://seekingalpha.com/news/3408483-asset-sales-ge-bring-leverage\" target=\"_blank\">We need to bring the leverage down</a>,\" <a href=\"https://www.cnbc.com/2018/11/12/ge-ceo-culp-says-he-will-use-asset-sales-to-raise-cash-and-bring-leverage-down-feels-the-urgency.html\" target=\"_blank\">Culp told CNBC</a> this morning, and that GE has \"got plenty of opportunities through assets sales to do that.\"</li> <li>\"I think [Culp] is <a href=\"https://www.cnbc.com/2018/11/12/ge-ceo-quick-comments-about-health-spinoff-could-mean-an-outright-sale.html\" target=\"_blank\">weighing all options</a> including the outright sale of  the business or parts of it,\" Melius Research CEO Scott Davis says, adding that Danaher (<a href='https://seekingalpha.com/symbol/DHR' title='Danaher Corporation'>DHR</a> <font color=\"red\">-2.2%</font>), the company that Culp ran as CEO during 2000-2014, would \"love\" to own the life sciences business of GE Healthcare.</li>\n<li>BlackRock chief equity strategist Kate Moore says GE\u2019s stock slump does not indicate \"something sinister happening in industrial conglomerates or the broader economy... because this is a <a href=\"https://www.wsj.com/articles/general-electric-shares-keep-falling-on-track-for-fourth-straight-session-of-declines-1542039574\" target=\"_blank\">specific security issue</a>.\"</li>\n<li>\"We do not think the businesses are fundamentally broken,\" says Credit Suisse's John Walsh, but \"modeling an appropriate near-term trough has proven difficult,\" adding that \"poor visibility into fundamentals coupled with uncertainty around liabilities keep us sidelined.\"</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408558\" data-linked=\"GE down another 5% as Culp comments fail to reassure investors\" data-tweet=\"$GE $GE $DHR - GE down another 5% as Culp comments fail to reassure investors https://seekingalpha.com/news/3408558-ge-down-another-5-culp-comments-fail-to-reassure-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3408558-ge-down-another-5-culp-comments-fail-to-reassure-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>70&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408555\" data-ts=\"1542043199\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIG\" target=\"_blank\">SIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408555-signet-tiffany-fall-on-report-of-de-beers-diamond-price-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Signet, Tiffany fall on report of De Beers diamond price cut</a></h4><ul>\n<li>Signet (NYSE:<a href='https://seekingalpha.com/symbol/SIG' title='Signet Jewelers Limited'>SIG</a>) is <font color=\"red\">down 4.1%</font> and Tiffany (NYSE:<a href='https://seekingalpha.com/symbol/TIF' title='Tiffany & Co.'>TIF</a>) is <font color=\"red\">off 3.1%</font> in moves being attributed to a reported price cut by De Beers (<a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>) on diamond prices.</li>\n<li>Source: Bloomberg</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3408555\" data-linked=\"Signet, Tiffany fall on report of De Beers diamond price cut\" data-tweet=\"$SIG $SIG $TIF - Signet, Tiffany fall on report of De Beers diamond price cut https://seekingalpha.com/news/3408555-signet-tiffany-fall-on-report-of-de-beers-diamond-price-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3408555-signet-tiffany-fall-on-report-of-de-beers-diamond-price-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408552\" data-ts=\"1542042849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSI\" target=\"_blank\">VSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408552-vitamin-shoppeplus-10-after-margins-improve\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vitamin Shoppe +10% after margins improve</a></h4><ul> <li>Vitamin Shoppre (NYSE:<a href='https://seekingalpha.com/symbol/VSI' title='Vitamin Shoppe, Inc.'>VSI</a>) is <font color=\"green\">up 10.0%</font> after reporting a higher adjusted operating margin in Q3 than anticipated (1.4% vs. +0.7% consensus).</li> <li>The margin improvement was brought up Vitamin Shoppe execs on the post-earnings conference call (<a href=\"https://seekingalpha.com/article/4219342-vitamin-shoppe-vsi-q3-2018-results-earnings-call-transcript\" target=\"_blank\">transcript</a>). \"During Q3, our private brand sales trend and penetration continued to improve to last year and our margin rate expanded over 200 basis points through successful negotiations for lower cost of goods,\" noted CMO Dave Mock.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3406343-vitamin-shoppes-mixed-q3-results\" target=\"_blank\">More on Vitamin Shoppe's mixed Q3 results</a> (Nov. 7)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3408552\" data-linked=\"Vitamin Shoppe +10% after margins improve\" data-tweet=\"$VSI - Vitamin Shoppe +10% after margins improve https://seekingalpha.com/news/3408552-vitamin-shoppeplus-10-after-margins-improve?source=tweet\" data-url=\"https://seekingalpha.com/news/3408552-vitamin-shoppeplus-10-after-margins-improve\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408551\" data-ts=\"1542042755\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408551-techcrunch-facebook-working-france-on-moderation-probe\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TechCrunch: Facebook working with France on moderation probe</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"red\">-2.4%</font>) will cooperate with a <a href=\"https://techcrunch.com/2018/11/12/facebook-to-let-french-regulators-investigate-on-moderation-processes/\" target=\"_blank\">French investigation</a> into human moderation vs. algorithm-powered moderation, TechCrunch says.</li>    <li>That means unprecedented access to internal Facebook processes.</li>    <li>The cooperation was spurred by informal talks between Facebook and France starting in May. For Facebook's part, it could mean regulation with a more granular hand with the company's cooperation rather than without it.</li>    <li>The probe will look at multiple steps including how flagging works, how Facebook identifies problematic content, how it ultimately decides on how problematic, and the process of taking down the content.</li>    <li>French President Emmanuel Macron says tech regulation needs to pursue a third way in terms of cooperation -- not an American way nor a Chinese way.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408551\" data-linked=\"TechCrunch: Facebook working with France on moderation probe\" data-tweet=\"$FB - TechCrunch: Facebook working with France on moderation probe https://seekingalpha.com/news/3408551-techcrunch-facebook-working-france-on-moderation-probe?source=tweet\" data-url=\"https://seekingalpha.com/news/3408551-techcrunch-facebook-working-france-on-moderation-probe\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408550\" data-ts=\"1542042586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKTR\" target=\"_blank\">NKTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408550-nektar-up-7-on-encouraging-nktrminus-214-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nektar up 7% on encouraging NKTR-214 data</a></h4><ul> <li>Nektar Therapeutics (<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color=\"green\">+7.3%</font>) bucks investors' sour mood with biotechs. Shares are up on almost 40% higher volume in reaction to its <a href=\"https://seekingalpha.com/pr/17329619-nektar-therapeutics-presents-new-clinical-preclinical-data-immuno-oncology-pipeline-2018\" target=\"_blank\">announcement </a>of positive data on candidate NKTR-214 during the SITC annual meeting in Washington, DC.</li> <li>Results from a Phase 1/2 trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02983045?titles=pivot-02&amp;lead=nektar+therapeutics&amp;rank=1\" target=\"_blank\">PIVOT-02</a>, evaluating CD-122-biased agonist NKTR-214 + Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.7%</font>) Opdivo (nivolumab) in first-line metastatic melanoma patients showed a 53% (n=20/38) overall response rate &#40;ORR&#41;, including nine complete responders. 85% (n=17/20) of the responders have sustained their responses. The disease control rate (responders + stable cancer) was 76% (n=29/38).</li> <li>The ORR was 43% (6/14) in PD-L1-negative patients and 68% (n=13/19) in PD-L1-positive patients.</li> <li>Additional preclinical data showed that NKTR-214 may boost anti-tumor immune responses when combined with therapies with complementary mechanisms of action (e.g., PARP inhibitors or radiation therapy).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408550\" data-linked=\"Nektar up 7% on encouraging NKTR-214 data\" data-tweet=\"$NKTR $NKTR $BMY - Nektar up 7% on encouraging NKTR-214 data https://seekingalpha.com/news/3408550-nektar-up-7-on-encouraging-nktrminus-214-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3408550-nektar-up-7-on-encouraging-nktrminus-214-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408548\" data-ts=\"1542042290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408548-ti-favors-single-network-discussing-teaming-vodafone-on-5g\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TI favors single network; discussing teaming with Vodafone on 5G</a></h4><ul>   <li>Amid discussions about an Open Fiber network deal, Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color=\"green\">+1.7%</font>) is still favoring a single network in country and exploring working with Open Fiber to achieve it, its CEO says.</li>    <li>\"Telecom Italia continues to support the idea of a single network in Italy, to avoid unnecessary duplication of infrastructure investment,\" CEO Amos Genish says.</li>    <li>He wants TI to control the network and replicate the situation in other countries: \"Deconsolidation of the network would put at risk not only the company\u2019s future, but also the digital ambitions of the country.\"</li>    <li>Meanwhile, Vodafone (<a href=\"http://seekingalpha.com/symbol/VOD\" target=\"_blank\">VOD</a> <font color=\"red\">-0.5%</font>) and Telecom Italia are talking about teaming up on next-gen wireless, via a joint 5G network in Italy, Bloomberg reports.</li>    <li>The two are aiming for a network deal as soon as the first quarter, according to the news service.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408548\" data-linked=\"TI favors single network; discussing teaming with Vodafone on 5G\" data-tweet=\"$TI $TI $VOD - TI favors single network; discussing teaming with Vodafone on 5G https://seekingalpha.com/news/3408548-ti-favors-single-network-discussing-teaming-vodafone-on-5g?source=tweet\" data-url=\"https://seekingalpha.com/news/3408548-ti-favors-single-network-discussing-teaming-vodafone-on-5g\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408546\" data-ts=\"1542042123\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UFPT\" target=\"_blank\">UFPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408546-kodak-and-ufp-technologies-consumer-gainers-british-american-tobacco-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kodak and UFP Technologies consumer gainers; British American Tobacco among losers</a></h4><ul> <li>\n<b>Gainers: </b>UFP Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/UFPT' title='UFP Technologies, Inc.'>UFPT</a>) <font color=\"green\">+9%</font>. Eastman Kodak Company (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a>) <font color=\"green\">+7%</font>.</li> <li>\n<b>Losers: </b>Nova LifeStyle (NASDAQ:<a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a>) <font color=\"red\">-14%</font>. Trinseo (NYSE:<a href='https://seekingalpha.com/symbol/TSE' title='Trinseo S.A.'>TSE</a>) <font color=\"red\">-10%</font>. Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) <font color=\"red\">-9%</font>. British American Tobacco (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTI' title='British American Tobacco p.l.c. &#40;American Depository Receipts&#41;'>BTI</a>) <font color=\"red\">-8%</font>. Naked Brand Group (NASDAQ:<a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408546\" data-linked=\"Kodak and UFP Technologies consumer gainers; British American Tobacco among losers\" data-tweet=\"$UFPT $UFPT $KODK - Kodak and UFP Technologies consumer gainers; British American Tobacco among losers https://seekingalpha.com/news/3408546-kodak-and-ufp-technologies-consumer-gainers-british-american-tobacco-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408546-kodak-and-ufp-technologies-consumer-gainers-british-american-tobacco-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408545\" data-ts=\"1542042023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408545-tech-lunch-break-apple-supplier-woes-sink-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech lunch break: Apple supplier woes sink sector</a></h4><ul> <li>Lumentum\u2019s<font color=\"red\"> -30.5%</font> cut Q2 guidance due to a customer trimming orders renews fears of weaker Apple<font color=\"red\"> -4.5% </font>iPhone sales. Analysts cut iPhone shipment targets particularly for the XR and XS Max models. And chipmaker/Apple supplier Infineon<font color=\"red\"> -8.4%</font> warned on softer 2019 growth due to environment uncertainty.</li> <li>Broad sector: The Technology Select Sector SPDR Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) is down <font color=\"red\">3.2%</font>, the S&amp;P 500 IT index is down<font color=\"red\"> 3.3%</font>, the tech-heavy Nasdaq 100 drops <font color=\"red\">2.9%</font>, and the Philadelphia Semiconductor Index<font color=\"red\"> plunges 4.5%</font> compared to the <font color=\"red\">2.6% </font>Nasdaq loss and <font color=\"red\">1.6%</font> for the S&amp;P 500.</li> <li>Related broad tech ETFs: <a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>, <a href='https://seekingalpha.com/symbol/VGT' title='Vanguard Information Technology ETF'>VGT</a>, <a href='https://seekingalpha.com/symbol/TECL' title='Direxion Technology Bull 3x Shares ETF'>TECL</a>, <a href='https://seekingalpha.com/symbol/FTEC' title='Fidelity MSCI Information Technology Index ETF'>FTEC</a>, <a href='https://seekingalpha.com/symbol/IYW' title='iShares U.S. Technology ETF'>IYW</a>, <a href='https://seekingalpha.com/symbol/ROM' title='ProShares Ultra Technology ETF'>ROM</a>, <a href='https://seekingalpha.com/symbol/QTEC' title='First Trust NASDAQ-100-Tech Index ETF'>QTEC</a>, <a href='https://seekingalpha.com/symbol/RYT' title='Invesco S&P 500 Equal Weight Technology ETF'>RYT</a>, <a href='https://seekingalpha.com/symbol/FNG' title='AdvisorShares New Tech and Media ETF'>FNG</a>, <a href='https://seekingalpha.com/symbol/TECS' title='Direxion Technology Bear 3x Shares ETF'>TECS</a>, <a href='https://seekingalpha.com/symbol/IGM' title='iShares North American Tech ETF'>IGM</a>, <a href='https://seekingalpha.com/symbol/FXL' title='First Trust Tech AlphaDEX ETF'>FXL</a>, <a href='https://seekingalpha.com/symbol/XNTK' title='SPDR NYSE Technology ETF'>XNTK</a>, <a href='https://seekingalpha.com/symbol/REW' title='ProShares UltraShort Technology ETF'>REW</a>, <a href='https://seekingalpha.com/symbol/JHMT' title='John Hancock Multifactor Technology ETF'>JHMT</a>, <a href='https://seekingalpha.com/symbol/XITK' title='SPDR Innovative Technology ETF'>XITK</a>.</li> <li>Top stories from the morning:</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408478-analysts-negative-iphone-shipments\" target=\"_blank\">Analysts negative on iPhone shipments</a> (Nov. 12)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408522-apple-suppliers-drop-lumentum-guide-iphone-target-cuts\" target=\"_blank\">Apple suppliers drop on Lumentum guide, iPhone target cuts</a> (Nov. 12)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408537-bad-news-apple-chip-stocks\" target=\"_blank\">More bad news for Apple, chip stocks</a> (Nov. 12)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408439-lumentum-drops-q2-guide-shipment-cut\" target=\"_blank\">Lumentum drops Q2 guide on shipment cut</a> (Nov. 12)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408349-sap-acquires-qualtrics-international-just-ipo\" target=\"_blank\">SAP acquires Qualtrics International just before IPO</a> (Nov. 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408545\" data-linked=\"Tech lunch break: Apple supplier woes sink sector\" data-tweet=\"$XLK $VGT $TECL - Tech lunch break: Apple supplier woes sink sector https://seekingalpha.com/news/3408545-tech-lunch-break-apple-supplier-woes-sink-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3408545-tech-lunch-break-apple-supplier-woes-sink-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408543\" data-ts=\"1542041798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GS\" target=\"_blank\">GS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408543-goldman-slumps-to-two-year-low-malaysia-seeks-full-refund-on-1mdb-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman slumps to two-year low as Malaysia seeks full refund on 1MDB deals</a></h4><ul> <li>Goldman Sachs (NYSE:<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a>) <font color=\"red\">sinks 5.5%</font> in midday trading after Malaysia's finance minister said the country wants<a href=\"https://www.bloomberg.com/news/articles/2018-11-12/malaysia-seeking-full-refund-from-goldman-sachs-for-1mdb-deals\" target=\"_blank\"> to get back </a>all the fees it paid to Goldman for arranging bond offerings for its scandal-ridden 1MDB fund.</li> <li>With former Goldman banker Tim Leissner pleading guilty for his role in the scandal, Goldman has \"admitted culpability,\" Lim Guan Eng said in a interview with radio station BFM, Bloomberg reports.</li> <li>Lim is seeking a full refund of the almost $600M Malaysia paid to Goldman for three bond deals.</li> <li>Claims of embezzlement and money laundering at the state fund 1MDB have led to investigations in the U.S., Singapore, and Switzerland.</li> <li>Goldman hasn't publicly admitted wrongdoing and has said it's cooperating with authorities.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3404166-two-former-goldman-bankers-charged-1mdb-case\" target=\"_blank\">Two former Goldman bankers charged in 1MDB case</a> (Nov. 1)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408543\" data-linked=\"Goldman slumps to two-year low as Malaysia seeks full refund on 1MDB deals\" data-tweet=\"$GS - Goldman slumps to two-year low as Malaysia seeks full refund on 1MDB deals https://seekingalpha.com/news/3408543-goldman-slumps-to-two-year-low-malaysia-seeks-full-refund-on-1mdb-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3408543-goldman-slumps-to-two-year-low-malaysia-seeks-full-refund-on-1mdb-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408542\" data-ts=\"1542041658\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYRSF\" target=\"_blank\">NYRSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408542-nyrstarminus-50-abn-amro-analyst-warns-shares-will-get-wiped-out\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nyrstar -50% as ABN Amro analyst warns shares will get wiped out</a></h4><ul> <li>Nyrstar (<a href='https://seekingalpha.com/symbol/NYRSF' title='Nyrstar NV'>OTC:NYRSF</a>) is cut in half to all-time lows in European trading after ABN Amro analysts tell investors to \"<a href=\"https://twitter.com/humenm/status/1061973752978853888\" target=\"_blank\">abandon ship</a>,\" slashing its stock price target to \u20ac0.01 from \u20ac1.</li> <li>Nyrstar, Europe\u2019s biggest zinc smelting company, is on an inevitable path toward a debt restructuring given its liquidity position and large debt and interest burden, the firm says.</li> <li>ABN Amro believes the most likely scenario is a debt-for-equity swap, possibly in combination with a private share placement to Trafigura, which would come at the cost of a full wipeout of current equity.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408542\" data-linked=\"Nyrstar -50% as ABN Amro analyst warns shares will get wiped out\" data-tweet=\"$NYRSF $NYRSY - Nyrstar -50% as ABN Amro analyst warns shares will get wiped out https://seekingalpha.com/news/3408542-nyrstarminus-50-abn-amro-analyst-warns-shares-will-get-wiped-out?source=tweet\" data-url=\"https://seekingalpha.com/news/3408542-nyrstarminus-50-abn-amro-analyst-warns-shares-will-get-wiped-out\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408541\" data-ts=\"1542041116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IONS\" target=\"_blank\">IONS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408541-biotechs-getting-slammed-again-xbi-down-almost-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs getting slammed again, XBI down almost 4%</a></h4><ul> <li>In an all-too-frequent narrative, biotechs are getting roughed up yet again. The SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color=\"red\">-3.5%</font>) is in the red, albeit on below-average volume. The ETF has lost ~22% of its value in a little over two months.</li> <li>One of the major overhangs is the uncertainty with future price increases, specifically the potential pushback from the Trump administration.</li> <li>Selected tickers: (<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"red\">-4.4%</font>)(<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color=\"red\">-6.9%</font>)(<a href='https://seekingalpha.com/symbol/FPRX' title='Five Prime Therapeutics, Inc.'>FPRX</a> <font color=\"red\">-2.3%</font>)(<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color=\"red\">-3.4%</font>)(<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a> <font color=\"red\">-4.2%</font>)(<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color=\"red\">-4.9%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color=\"red\">-3.4%</font>)(<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color=\"red\">-2.7%</font>)(<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color=\"red\">-7.6%</font>)(<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color=\"red\">-0.8%</font>)(<a href='https://seekingalpha.com/symbol/UTHR' title='United Therapeutics Corporation'>UTHR</a> <font color=\"red\">-1.2%</font>)(<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color=\"red\">-6.3%</font>)(<a href='https://seekingalpha.com/symbol/CLVS' title='Clovis Oncology'>CLVS</a> <font color=\"red\">-9.8%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color=\"red\">-2.8%</font>)(<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color=\"red\">-5.6%</font>)(<a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a> <font color=\"red\">-6.9%</font>)(<a href='https://seekingalpha.com/symbol/ALKS' title='Alkermes plc'>ALKS</a> <font color=\"red\">-4.6%</font>)(<a href='https://seekingalpha.com/symbol/ALXN' title='Alexion Pharmaceuticals, Inc.'>ALXN</a> <font color=\"red\">-2.6%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color=\"red\">-4.2%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"red\">-0.8%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color=\"red\">-1.6%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color=\"red\">-0.6%</font>)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3401631-trump-mulling-tieing-u-s-drug-prices-europes\" target=\"_blank\">Trump mulling tieing U.S. drug prices to Europe's</a> (Oct. 26)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408541\" data-linked=\"Biotechs getting slammed again, XBI down almost 4%\" data-tweet=\"$IONS $XBI $IONS - Biotechs getting slammed again, XBI down almost 4% https://seekingalpha.com/news/3408541-biotechs-getting-slammed-again-xbi-down-almost-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3408541-biotechs-getting-slammed-again-xbi-down-almost-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408539\" data-ts=\"1542040635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408539-teslaminus-4-volkswagen-talks-big-game\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla -4% as Volkswagen talks a big game</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is <font color=\"red\">down 4.3%</font> on the day and it's possible that investors may be reacting to the flurry of EV news coming out of Germany.</li> <li>Volkswagen (<a href='https://seekingalpha.com/symbol/VWAGY' title='Volkswagen AG ADR'>OTCPK:VWAGY</a>) CEO Herbert Diess stated that the German automaker wants to attack Tesla with aggressive prices. \"We will be cheaper than Tesla, and then we will have big economies of scale,\" Diess told German publication <a href=\"https://www.automobilwoche.de/\" target=\"_blank\">Automobilwoche</a>.</li> <li>Diess also said that Volkswagen's electric car plant in Germnay is \"booked\" for 50M electric cars and the company has sourced the batteries for those 50M units.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408539\" data-linked=\"Tesla -4% as Volkswagen talks a big game\" data-tweet=\"$TSLA $TSLA $VWAGY - Tesla -4% as Volkswagen talks a big game https://seekingalpha.com/news/3408539-teslaminus-4-volkswagen-talks-big-game?source=tweet\" data-url=\"https://seekingalpha.com/news/3408539-teslaminus-4-volkswagen-talks-big-game\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>232&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408538\" data-ts=\"1542040521\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408538-share-losses-accelerate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Share losses accelerate</a></h4><ul>\n<li>A <font color=\"red\">7% decline</font> in General Electric and <font color=\"red\">5% drop-off </font>for Apple are helping the averages to big declines just before the noon hour.</li>\n<li>The Nasdaq is <font color=\"red\">off 2.8%</font>, the S&amp;P 500 <font color=\"red\">1.6%</font>, and Dow <font color=\"red\">1.7%</font>. The Russell 2000 is <font color=\"red\">down 1.55%</font>.</li>\n<li>Larry Culp's CNBC appearance was a dud, with the GE CEO <a href=\"https://seekingalpha.com/news/3408483-asset-sales-ge-bring-leverage\" target=\"_blank\">talking asset sales</a> just days after the company asserted its \"fundamentally strong\" position.</li>\n<li>Apple, meanwhile, is reeling from <a href=\"https://seekingalpha.com/news/3408478-analysts-negative-iphone-shipments\" target=\"_blank\">a nasty research note</a> indicating big iPhone order cuts, as well as one of its key <a href=\"https://seekingalpha.com/news/3408446-apple-slips-supplier-cuts-guidance\" target=\"_blank\">suppliers slashing</a> guidance</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408538\" data-linked=\"Share losses accelerate\" data-tweet=\"Share losses accelerate https://seekingalpha.com/news/3408538-share-losses-accelerate?source=tweet\" data-url=\"https://seekingalpha.com/news/3408538-share-losses-accelerate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408537\" data-ts=\"1542040416\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408537-bad-news-for-apple-chip-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More bad news for Apple, chip stocks</a></h4><ul>\n<li>        Noted Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='red'>-5%</font>) analyst Ming-Chi Kuo <a href=\"https://9to5mac.com/2018/11/12/kuo-2018-2019-iphone-sales-decline/\" target=\"_blank\">cuts</a> his iPhone XR  shipment estimates from 100M to 70M through September 2019.</li>\n<li>               Kuo blames negative consumer confidence due to the US-China trade ware, competition in emerging markets, and customers wanting features like dual cameras that are lacking in the XR. </li>\n<li>               Kuo maintains his Q4 shipment estimate of 80M thinking the XR fall will be offset by higher sales of the XS series and older models. But the analyst sees Q1 shipments dropping Y/Y to the 47M to 52M range (1Q18 sales: 52M). </li>\n<li>               <strong>Another supplier cut: </strong>Chipmaker Infineon (<a href='https://seekingalpha.com/symbol/IFNNY' title='Infineon Technologies AG ADR'>OTCQX:IFNNY</a> <font color='red'>-8.5%</font>) <a href=\"https://www.ft.com/content/d0b2af5e-e67f-11e8-8a85-04b8afea6ea3\" target=\"_blank\">cuts</a> its 2019 Y/Y growth to 9% from the prior 10% guidance. </li>\n<li>               Management says the outlook \u201cbakes in a higher probability of an international economic slowdown\u201d and that the company\u2019s \u201cenvironment is very challenging at present\u201d with \u201cmany uncertainties.\u201d  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408439-lumentum-drops-q2-guide-shipment-cut\" target=\"_blank\">Lumentum drops Q2 guide on shipment cut</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408478-analysts-negative-iphone-shipments\" target=\"_blank\">Analysts negative on iPhone shipments</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408522-apple-suppliers-drop-lumentum-guide-iphone-target-cuts\" target=\"_blank\">Apple suppliers drop on Lumentum guide, iPhone target cuts</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408537\" data-linked=\"More bad news for Apple, chip stocks\" data-tweet=\"$AAPL $AAPL $IFNNY - More bad news for Apple, chip stocks https://seekingalpha.com/news/3408537-bad-news-for-apple-chip-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3408537-bad-news-for-apple-chip-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408535\" data-ts=\"1542039824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FE\" target=\"_blank\">FE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408535-firstenergy-agrees-to-return-money-to-customers-ties-plan-to-wire-upgrades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FirstEnergy agrees to return money to customers, ties plan to wire upgrades</a></h4><ul> <li>FirstEnergy (<a href='https://seekingalpha.com/symbol/FE' title='FirstEnergy Corp'>FE</a> <font color='green'>+2.9%</font>) says it filed a stipulated agreement with Ohio's Public Utilities Commission to <a href=\"https://seekingalpha.com/pr/17329580-firstenergy-ohio-utilities-file-settlement-provide-900-million-federal-tax-refund-customers\" target=\"_blank\">return $900M to customers</a> as a result of federal tax cuts while <a href=\"http://www.toledoblade.com/business/energy/2018/11/09/firstenergy-to-return-money-from-federal-tax-cut/stories/20181109155\" target=\"_blank\">tying the agreement</a> to its plan to upgrade its electric distribution grid to new smart technology.</li> <li>FE says its upgrade plan would cost $516M over three years, and the utility is seeking approval to recover its costs through a special fee it will charge customers.</li> <li>The agreement is subject to approval by the Ohio PUC, but the commission\u2019s staff already has recommended approval of the proposed settlement.</li> <li>Separately, FE <a href=\"https://seekingalpha.com/news/3408271-firstenergy-declares-0_38-dividend\" target=\"_blank\">raises its quarterly dividend</a> and approves a new dividend policy that includes a targeted payout ratio of 55%-65% of its operating earnings, guides FY 2019 EPS of $2.45-$2.75 vs. analyst consensus $2.53 and affirms its compound annual operating earnings growth rate  projection of 6%-8% through 2021.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408535\" data-linked=\"FirstEnergy agrees to return money to customers, ties plan to wire upgrades\" data-tweet=\"$FE - FirstEnergy agrees to return money to customers, ties plan to wire upgrades https://seekingalpha.com/news/3408535-firstenergy-agrees-to-return-money-to-customers-ties-plan-to-wire-upgrades?source=tweet\" data-url=\"https://seekingalpha.com/news/3408535-firstenergy-agrees-to-return-money-to-customers-ties-plan-to-wire-upgrades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408533\" data-ts=\"1542039461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSP\" target=\"_blank\">SSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408533-scrippsplus-5_8-benchmark-takes-in-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps +5.8% as Benchmark takes in earnings beat</a></h4><ul>   <li>E.W. Scripps (NASDAQ:<a href='https://seekingalpha.com/symbol/SSP' title='The E.W. Scripps Company'>SSP</a>) is <font color=\"green\">up 5.8%</font> in a bit of a delayed response to its Friday earnings beat.</li>    <li>Shares actually <font color=\"red\">fell 5%</font> that day despite riding political advertising to a swing to profit and <a href=\"https://seekingalpha.com/news/3408215-scripps-minus-4_7-percent-beat-q3-strong-political-ads\" target=\"_blank\">topping expectations in its results</a>, along with providing strong local media growth guidance.</li>    <li>Now Benchmark is raising its price target along with revenue and EBITDA forecasts. The firm bumped its price target to $22 from $21, now implying 23.5% upside.</li>    <li>It's boosting full-year revenue and EBITDA expectations by $10M, saying strong sub trends in the past year will be a tailwind for a company has is seeing more than 90% of subs renewing through 2020.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408533\" data-linked=\"Scripps +5.8% as Benchmark takes in earnings beat\" data-tweet=\"$SSP - Scripps +5.8% as Benchmark takes in earnings beat https://seekingalpha.com/news/3408533-scrippsplus-5_8-benchmark-takes-in-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3408533-scrippsplus-5_8-benchmark-takes-in-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408532\" data-ts=\"1542039259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMT\" target=\"_blank\">AIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408532-nestl-health-science-to-up-stake-in-aimmune-to-19-shares-down-8-on-dilution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nestlé Health Science to up stake in Aimmune to 19%; shares down 8% on dilution</a></h4><ul> <li>Aimmune Therapeutics (<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color=\"red\">-8%</font>) <a href=\"https://seekingalpha.com/pr/17330007-aimmune-therapeutics-announces-additional-equity-investment-nestle-health-science\" target=\"_blank\">announces </a>that Nestlé Health Science will make an additional $98M investment in the company via the purchase of ~3.7M newly issued common shares at $30.27 per share. The transaction will increase its stake to ~19%. The new shares represent over 9% of the float.</li> <li>The companies also inked a two-year extension to their collaboration agreement, originally two years, aimed at developing therapies for food allergies.</li>\n<li>\n<strong>Update</strong>: On November 28, the company <a href=\"https://seekingalpha.com/pr/17344262-aimmune-therapeutics-announces-closing-98-million-investment-nestle-health-science\" target=\"_blank\">announced </a>the closing of the investment.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408532\" data-linked=\"Nestlé Health Science to up stake in Aimmune to 19%; shares down 8% on dilution\" data-tweet=\"$AIMT - Nestlé Health Science to up stake in Aimmune to 19%; shares down 8% on dilution https://seekingalpha.com/news/3408532-nestl-health-science-to-up-stake-in-aimmune-to-19-shares-down-8-on-dilution?source=tweet\" data-url=\"https://seekingalpha.com/news/3408532-nestl-health-science-to-up-stake-in-aimmune-to-19-shares-down-8-on-dilution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408526\" data-ts=\"1542038444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GILT\" target=\"_blank\">GILT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408526-gilat-satellite-slides-7_9-post-q3-results-despite-strong-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gilat Satellite slides 7.9% post Q3 results despite strong margins</a></h4><ul>\n<li>Gilat Satellite (<a href='https://seekingalpha.com/symbol/GILT' title='Gilat Satellite Networks Ltd.'>GILT</a> <font color=\"red\">-7.9%</font>) reports <a href=\"https://seekingalpha.com/pr/17329952-gilat-reports-strong-profitability-q3-2018-raises-objectives-2018-operating-profit-ebitda\" target=\"_blank\">Q3</a> revenue decrease of 10.2% Y/Y to $62.8M.</li>\n<li>Overall Q3 margin: Gross <font color=\"green\">increased 950 bps</font> to 38.5%; operating <font color=\"green\">increased 483 bps</font> to 9.6%; Adj. EBITDA <font color=\"green\">increased 433 bps</font> to 14.5%.</li>\n<li>Gazprom Space Systems and Gilat Sign $18M Contract to Provide Broadband Connectivity Across Russia over New Yamal 601 Ka Satellite.</li>\n<li>\n<strong>Revised 2018 Outlook:</strong> Revenue $265-275M; Operating income $22-24M; Adj. EBITDA income $35-37M.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408417-gilat-satellite-reports-q3-results\" target=\"_blank\">Gilat Satellite reports Q3 results</a> (Nov. 12 2018)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408526\" data-linked=\"Gilat Satellite slides 7.9% post Q3 results despite strong margins\" data-tweet=\"$GILT - Gilat Satellite slides 7.9% post Q3 results despite strong margins https://seekingalpha.com/news/3408526-gilat-satellite-slides-7_9-post-q3-results-despite-strong-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3408526-gilat-satellite-slides-7_9-post-q3-results-despite-strong-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408525\" data-ts=\"1542038202\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TME\" target=\"_blank\">TME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408525-netease-raises-600m-plus-for-cloud-music-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NetEase raises $600M-plus for cloud music unit</a></h4><ul>   <li>In an update on financing for its music arm, NetEase (<a href=\"http://seekingalpha.com/symbol/NTES\" target=\"_blank\">NTES</a> <font color=\"red\">-5.2%</font>) says it <a href=\"https://seekingalpha.com/pr/17329954-netease-provides-update-financing-netease-cloud-music\" target=\"_blank\">raised more than $600M</a> in a round of fund-raising for NetEase Cloud Music.</li>    <li>That round included Baidu (<a href=\"http://seekingalpha.com/symbol/BIDU\" target=\"_blank\">BIDU</a> <font color=\"red\">-2%</font>), a strategic partner, as well as General Atlantic, Boyu Capital and others.</li>    <li>NetEase remains the controlling shareholder of NetEase Cloud Music after the funding round. The music streaming platform competes with Tencent (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color=\"red\">-3.1%</font>), which has its own music operation (NYSE:<a href='https://seekingalpha.com/symbol/TME' title='Tencent Music Entertainment Group'>TME</a>) it hopes to bring public (an effort <a href=\"https://seekingalpha.com/news/3396839-markets-reeling-tencent-music-pauses-ipo\" target=\"_blank\">paused last month</a>).</li>    <li>NetEase shares <a href=\"https://seekingalpha.com/news/3397044-reports-baidu-takes-strategic-position-netease-music\" target=\"_blank\">moved up a month ago</a> in U.S. trading as word of the new funding round circulated.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408525\" data-linked=\"NetEase raises $600M-plus for cloud music unit\" data-tweet=\"$TME $TME $NTES - NetEase raises $600M-plus for cloud music unit https://seekingalpha.com/news/3408525-netease-raises-600m-plus-for-cloud-music-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3408525-netease-raises-600m-plus-for-cloud-music-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408524\" data-ts=\"1542038188\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSLS\" target=\"_blank\">RSLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408524-reshape-up-32-following-va-contract-for-intragastric-balloon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReShape up 32% following VA contract for intragastric balloon</a></h4><ul> <li>Thinly traded nano cap ReShape Lifesciences (<a href='https://seekingalpha.com/symbol/RSLS' title='ReShape Lifesciences Inc.'>OTC:RSLS</a> <font color=\"green\">+32.4%</font>) is up on a whopping 69x surge in volume.</li> <li>Last week, the company reverse split its shares 1:140 and announced a VA contract for the ReShape Balloon.</li> <li>Shares dropped the day after, weighed down by intragastric balloon competitor Apollo Endosurgery's Q3 miss.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3407434-reshape-lifesciences-executes-1-140-reverse-split-announces-va-contract-shares-23-percent\" target=\"_blank\">Reshape Lifesciences executes 1:140 reverse split; announces VA contract; shares up 23% premarket</a> (Nov. 8)</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3408041-apollo-endosurgery-23-percent-premarket-q3-miss\" target=\"_blank\">Apollo Endosurgery down 23% premarket after Q3 miss</a> (Nov. 9)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408524\" data-linked=\"ReShape up 32% following VA contract for intragastric balloon\" data-tweet=\"$RSLS - ReShape up 32% following VA contract for intragastric balloon https://seekingalpha.com/news/3408524-reshape-up-32-following-va-contract-for-intragastric-balloon?source=tweet\" data-url=\"https://seekingalpha.com/news/3408524-reshape-up-32-following-va-contract-for-intragastric-balloon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408522\" data-ts=\"1542037771\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRUS\" target=\"_blank\">CRUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408522-apple-suppliers-drop-on-lumentum-guide-iphone-target-cuts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple suppliers drop on Lumentum guide, iPhone target cuts</a></h4><ul>\n<li>        Apple\u2019s iPhone suppliers are dropping after peer Lumentum lowered guidance on cut shipments and analysts warned of soft iPhone sales.</li>\n<li>                  On the move: Cirrus Logic (<a href='https://seekingalpha.com/symbol/CRUS' title='Cirrus Logic, Inc.'>CRUS</a> <font color='red'>-11%</font>), Finisar (<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> <font color='red'>-4.7%</font>), II-VI (<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> <font color='red'>-11.5%</font>), STMicroelectronics (<a href='https://seekingalpha.com/symbol/STM' title='STMicroelectronics NV'>STM</a> <font color='red'>-7%</font>), Skyworks Solutions (<a href='https://seekingalpha.com/symbol/SWKS' title='Skyworks Solutions, Inc.'>SWKS</a> <font color='red'>-4.5%</font>), Qorvo (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='red'>-7%</font>), Broadcom (<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a> <font color='red'>-6.8%</font>), Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='red'>-4.7%</font>), Cypress Semi (<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a> <font color='red'>-3.6%</font>), Texas Instruments (<a href='https://seekingalpha.com/symbol/TXN' title='Texas Instruments Inc.'>TXN</a> <font color='red'>-2.5%</font>), Amkor Tech (<a href='https://seekingalpha.com/symbol/AMKR' title='Amkor Technology, Inc.'>AMKR</a> <font color='red'>-3%</font>), Amphenol (<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar'>AMPH</a> <font color='red'>-4.4%</font>), Analog Devices (<a href='https://seekingalpha.com/symbol/ADI' title='Analog Devices Inc.'>ADI</a> <font color='red'>-2.6%</font>), Corning (<a href='https://seekingalpha.com/symbol/GLW' title='Corning Inc.'>GLW</a> <font color='red'>-3.3%</font>), Diodes (<a href='https://seekingalpha.com/symbol/DIOD' title='Diodes Incorporated'>DIOD</a> <font color='red'>-3.7%</font>), Infineon (<a href='https://seekingalpha.com/symbol/IFNNY' title='Infineon Technologies AG ADR'>OTCQX:IFNNY</a> <font color='red'>-9.1%</font>), Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>-2.1%</font>), Jabil (<a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a> <font color='red'>-3.8%</font>), KEMET (<a href='https://seekingalpha.com/symbol/KEM' title='KEMET Corp.'>KEM</a> <font color='red'>-9.8%</font>), Knowles (<a href='https://seekingalpha.com/symbol/KN' title='Knowles Corporation'>KN</a> <font color='red'>-9.9%</font>), Maxim Integrated (<a href='https://seekingalpha.com/symbol/MXIM' title='Maxim Integrated Products, Inc.'>MXIM</a> <font color='red'>-1.7%</font>), Microchip (<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a> <font color='red'>-2.3%</font>), NXP Semiconductors (<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color='red'>-3.3%</font>), ON Semi (<a href='https://seekingalpha.com/symbol/ON' title='ON Semiconductor Corporation'>ON</a> <font color='red'>-4.6%</font>), Qualcomm (<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a> <font color='red'>-2.7%</font>), Seagate (<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a> <font color='red'>-2.2%</font>), TSMC (<a href='https://seekingalpha.com/symbol/TSM' title='Taiwan Semiconductor Manufacturing Company Ltd.'>TSM</a> <font color='red'>-2.2%</font>), Western Digital (<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a> <font color='red'>-4.4%</font>).    </li>\n<li>               Apple\u2019s <a href=\"https://www.apple.com/supplier-responsibility/pdf/Apple-Supplier-List.pdf\" target=\"_blank\">supplier list</a> (February 2018).  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408402-cit-steps-skyworks-sidelines\" target=\"_blank\">Cit steps to Skyworks sidelines</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408406-citi-trims-qorvo-target\" target=\"_blank\">Citi trims Qorvo target</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408486-finisar-upgraded-goldman-trimmed-craig-hallum-buyout-deal\" target=\"_blank\">Finisar upgraded at Goldman, trimmed at Craig-Hallum after buyout deal</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408439-lumentum-drops-q2-guide-shipment-cut\" target=\"_blank\">Lumentum drops Q2 guide on shipment cut</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408446-apple-slips-supplier-cuts-guidance\" target=\"_blank\">Apple slips after supplier cuts guidance</a> (Nov. 12)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408478-analysts-negative-iphone-shipments\" target=\"_blank\">Analysts negative on iPhone shipments</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408522\" data-linked=\"Apple suppliers drop on Lumentum guide, iPhone target cuts\" data-tweet=\"$CRUS $CRUS $FNSR - Apple suppliers drop on Lumentum guide, iPhone target cuts https://seekingalpha.com/news/3408522-apple-suppliers-drop-on-lumentum-guide-iphone-target-cuts?source=tweet\" data-url=\"https://seekingalpha.com/news/3408522-apple-suppliers-drop-on-lumentum-guide-iphone-target-cuts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408520\" data-ts=\"1542037208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFI\" target=\"_blank\">INFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408520-investors-unimpressed-preliminary-data-on-infinity-pharmas-ipiminus-549-in-pdminus-1-l1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors unimpressed with preliminary data on Infinity Pharma&#39;s IPI-549 in PD-1/L1 inhibitor-resistant cancer patients; shares down 29%</a></h4><ul> <li>Thinly traded nano cap Infinity Pharmaceuticals (<a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color=\"red\">-29.4%</font>) slumps on double normal volume in apparent response to <a href=\"https://seekingalpha.com/pr/17329674-infinity-reports-clinical-translational-data-expansion-cohorts-mario-1-phase-1b-study\" target=\"_blank\">early-stage data</a> on IPI-549, combined with Bristol-Myers Squibb's (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-0.5%</font>) Opdivo (nivolumab), in treatment-resistant cancer patients who failed to respond to anti-PD-1/L1 therapy. The results were presented at the SITC annual meeting in Washington, DC.</li> <li>The data were generated in a Phase 1b clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02637531?lead=infinity+pharmaceuticals&amp;rank=1\" target=\"_blank\">MARIO-1</a>, in 200 patients with solid tumors. Most participants had received three prior lines of therapies and were resistant to anti-PD1/L1 treatment.</li> <li>In 44 evaluable patients the disease control rate (responders + stable cancer) was 34% (n=15/44), but there was only one partial responder, implying a response rate of 2%.</li> <li>One patient with triple negative breast cancer &#40;TNBC&#41; experienced a 26% reduction in target lesions at the first assessment. One patient with advanced mesothelioma partially responded.</li> <li>The company intends to expand the melanoma cohort to 40 patients and will expand the TNBC cohort as well.</li> <li>A Phase 2 trial, MARIO-275, assessing IPI-549 + Opdivo in ~150 checkpoint inhibitor-naïve advanced urothelial cancer patients who have progressed or relapsed after platinum-based chemo is next up. The primary endpoint will be overall response rate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408520\" data-linked=\"Investors unimpressed with preliminary data on Infinity Pharma&#39;s IPI-549 in PD-1/L1 inhibitor-resistant cancer patients; shares down 29%\" data-tweet=\"$INFI $INFI $BMY - Investors unimpressed with preliminary data on Infinity Pharma&#39;s IPI-549 in PD-1/L1 inhibitor-resistant cancer patients; shares down 29% https://seekingalpha.com/news/3408520-investors-unimpressed-preliminary-data-on-infinity-pharmas-ipiminus-549-in-pdminus-1-l1?source=tweet\" data-url=\"https://seekingalpha.com/news/3408520-investors-unimpressed-preliminary-data-on-infinity-pharmas-ipiminus-549-in-pdminus-1-l1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408518\" data-ts=\"1542036444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACM\" target=\"_blank\">ACM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408518-aecom-slides-after-soft-profit-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aecom slides after soft profit guidance</a></h4><ul> <li>Aecom (<a href='https://seekingalpha.com/symbol/ACM' title='AECOM Technology Corporation'>ACM</a> <font color='red'>-8.3%</font>) slides after the company sets disappointing guidance.</li> <li>The outlook from Aecom for full-year EPS is $2.60 to $2.90 vs. $3.01 consensus.</li> <li>CEO update: \"Our adjusted EBITDA for the fourth quarter and full year was below our expectations due to the timing of AECOM Capital asset sales, which we now expect in 2019, and execution challenges on a handful of projects in the Construction Services segment. Importantly, we are taking strategic actions from a position of strength that we expect will substantially improve our profitability and position us to fully capitalize on our record $54 billion backlog, which is reflected in our guidance for 12% adjusted EBITDA growth in fiscal 2019.\"</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408378-aecom-technology-beats-0_01-beats-revenue\" target=\"_blank\">AECOM Technology beats by $0.01, beats on revenue</a> (Nov. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408518\" data-linked=\"Aecom slides after soft profit guidance\" data-tweet=\"$ACM - Aecom slides after soft profit guidance https://seekingalpha.com/news/3408518-aecom-slides-after-soft-profit-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3408518-aecom-slides-after-soft-profit-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408513\" data-ts=\"1542035722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408513-dorsey-twitters-edit-button-under-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dorsey: Twitter&#39;s edit button under development</a></h4><ul>   <li>Twitter's (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color=\"red\">-3.6%</font>) much-discussed \"edit button\" feature may be <a href=\"https://www.indiatimes.com/technology/news/twitter-ceo-jack-dorsey-finally-realises-people-want-edit-button-says-they-re-working-on-it-356531.html\" target=\"_blank\">closer to reality</a> than before, based on CEO Jack Dorsey's comments in India today.</li>    <li>Speaking at Indian Institute of Technology in New Delhi, Dorsey says the company's interested in implementing the feature to fix typos. Currently there's no way to edit a tweet once it's out, though they can be deleted entirely.</li>    <li>\"You have to pay attention to what are the use cases for the edit button,\" he says. \"A lot of people want the edit button because they want to quickly fix a mistake they made. Like a misspelling or tweeting the wrong URL. That's a lot more achievable than allowing people to edit any tweet all the way back in time.\"</li>    <li>The company's been thinking about the feature a while but \"can't just rush it out,\" Dorsey says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408513\" data-linked=\"Dorsey: Twitter&#39;s edit button under development\" data-tweet=\"$TWTR - Dorsey: Twitter&#39;s edit button under development https://seekingalpha.com/news/3408513-dorsey-twitters-edit-button-under-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3408513-dorsey-twitters-edit-button-under-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408512\" data-ts=\"1542035647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408512-pg-and-eminus-23-after-initial-trading-halt-on-volatility\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E -23% after initial trading halt on volatility</a></h4><ul> <li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color=\"red\">-23.7%</font>) plunges to multiyear lows as trading resumes following an early halt on extreme volatility - an event not often seen in a publicly traded utility company - on fears over the current <a href=\"https://seekingalpha.com/news/3408450-pg-and-e-minus-12-percent-edison-minus-6_5-percent-california-wildfires-rage\" target=\"_blank\">California wildfires</a>.</li> <li>Evercore ISI analyst Greg Gordon <a href=\"https://finance.yahoo.com/news/pg-e-drops-analysts-seek-131458809.html\" target=\"_blank\">cuts PG&amp;E\u2019s price target</a> to $49 from $55, based on a $3.5B \"exposure placeholder\" for the Camp Fire, and says every $1B of higher exposure to Camp Fire liability would hit the firm\u2019s price target outlook by a little over $1/share.</li> <li>Gordon notes PCG closed Friday at just above Q3 book value of $37.60/share, discounting $20B-plus of exposure to fire liabilities, and could trade lower but believes \"there is value here\" - shares have seen slumped to ~$30/share.</li> <li>Goldman Sachs analyst Michael Lapides notes California\u2019s wildfire legislation that passed in late August does not contain provisions regarding wildfire recovery for potential 2018 fires.</li>\n<li>The utility sector SPDR (+0.2%) is holding up relatively well despite the sharp losses in PCG and Edison International (<a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color=\"red\">-13%</font>).</li>\n<li>ETFs: <a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a>, <a href='https://seekingalpha.com/symbol/UTG' title='Reaves Utility Income Fund'>UTG</a>, <a href='https://seekingalpha.com/symbol/VPU' title='Vanguard Utilities ETF'>VPU</a>, <a href='https://seekingalpha.com/symbol/GUT' title='Gabelli Utility Trust'>GUT</a>, <a href='https://seekingalpha.com/symbol/IDU' title='iShares U.S. Utilities ETF'>IDU</a>, <a href='https://seekingalpha.com/symbol/BUI' title='BlackRock Utility&Infrastructure Trust'>BUI</a>, <a href='https://seekingalpha.com/symbol/FUTY' title='Fidelity MSCI Utilities Index ETF'>FUTY</a>, <a href='https://seekingalpha.com/symbol/RYU' title='Invesco S&P Equal Weight Utilities ETF'>RYU</a>, <a href='https://seekingalpha.com/symbol/UPW' title='ProShares Ultra Utilities ETF'>UPW</a>, <a href='https://seekingalpha.com/symbol/PSCU' title='Invesco S&P SmallCap Utilities Portfolio ETF'>PSCU</a>, <a href='https://seekingalpha.com/symbol/FXU' title='First Trust Utilities AlphaDEX ETF'>FXU</a>, <a href='https://seekingalpha.com/symbol/SDP' title='ProShares UltraShort Utilities ETF'>SDP</a>, <a href='https://seekingalpha.com/symbol/PUI' title='Invesco DWA Utilities Momentum Portfolio ETF'>PUI</a>, <a href='https://seekingalpha.com/symbol/FUGAX' title='Fidelity Advisor® Utilities Fund A'>FUGAX</a>, <a href='https://seekingalpha.com/symbol/JHMU' title='John Hancock Multifactor Utilities ETF'>JHMU</a>, <a href='https://seekingalpha.com/symbol/BUYN' title='USCF SummerHaven SHPEN Index Fund'>BUYN</a>, <a href='https://seekingalpha.com/symbol/XU' title='Elkhorn S&P MidCap Utilities ETF'>XU</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3408512\" data-linked=\"PG&amp;E -23% after initial trading halt on volatility\" data-tweet=\"$PCG $PCG $EIX - PG&amp;E -23% after initial trading halt on volatility https://seekingalpha.com/news/3408512-pg-and-eminus-23-after-initial-trading-halt-on-volatility?source=tweet\" data-url=\"https://seekingalpha.com/news/3408512-pg-and-eminus-23-after-initial-trading-halt-on-volatility\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408510\" data-ts=\"1542035448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCVL\" target=\"_blank\">SCVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408510-shoe-carnivalplus-5-after-pivotal-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shoe Carnival +5% after Pivotal upgrade</a></h4><ul> <li>Shoe Carnival (NASDAQ:<a href='https://seekingalpha.com/symbol/SCVL' title='Shoe Carnival, Inc.'>SCVL</a>) trades <font color=\"green\">up 4.9%</font> after the retailer is upgraded by Pivotal Research to a Buy rating from Hold.</li> <li>The bullish call on Shoe Carnival arrives just ahead of the company's Q3 earnings report due out on November 15.</li> <li>Pivotal lifts its Q3 EPS estimate on SCVL to $0.59 vs. $0.56 prior and $0.58 consensus.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408510\" data-linked=\"Shoe Carnival +5% after Pivotal upgrade\" data-tweet=\"$SCVL - Shoe Carnival +5% after Pivotal upgrade https://seekingalpha.com/news/3408510-shoe-carnivalplus-5-after-pivotal-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3408510-shoe-carnivalplus-5-after-pivotal-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408509\" data-ts=\"1542035345\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTNB\" target=\"_blank\">MTNB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408509-amarin-selloff-pressures-matinas-bio-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin selloff pressures Matinas Bio, down 10%</a></h4><ul> <li>Matinas BioPharma (<a href='https://seekingalpha.com/symbol/MTNB' title='Matinas Biopharma Holdings, Inc.'>MTNB</a> <font color=\"red\">-9.9%</font>) is down on almost 30% higher volume in apparent sympathy with Amarin (<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a> <font color=\"red\">-10.8%</font>) after the latter released results from a large-scale study of Vascepa (icosapent ethyl), a form of omega-3 fatty acid.</li> <li>Matinas is developing <a href=\"https://www.matinasbiopharma.com/mat9001\" target=\"_blank\">MAT9001</a>, an omega-3 fatty acid, for the treatment of patients with abnormally high levels of triglycerides (greater than 500 mg/dL), the same patient population as Vascepa.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408458-amarin-14-percent-premarket-scrutiny-reduce-study\" target=\"_blank\">Amarin down 14% premarket on scrutiny of REDUCE-IT study</a> (Nov. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408509\" data-linked=\"Amarin selloff pressures Matinas Bio, down 10%\" data-tweet=\"$MTNB $MTNB $AMRN - Amarin selloff pressures Matinas Bio, down 10% https://seekingalpha.com/news/3408509-amarin-selloff-pressures-matinas-bio-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3408509-amarin-selloff-pressures-matinas-bio-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408500\" data-ts=\"1542034182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABMD\" target=\"_blank\">ABMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408500-abiomed-down-11-despite-positive-impella-cp-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abiomed down 11% despite positive Impella CP data</a></h4><ul> <li>Abiomed (<a href='https://seekingalpha.com/symbol/ABMD' title='ABIOMED, Inc.'>ABMD</a> <font color=\"red\">-10.6%</font>) investors appear disappointed with <a href=\"https://seekingalpha.com/pr/17329715-fda-safety-study-unloading-left-ventricle-30-minutes-prior-reperfusion-heart-attack-patients\" target=\"_blank\">study results</a> that showed the benefits of unloading the left ventricle with the Impella CP heart pump for 30 minutes prior to reperfusion (restoring blood flow) in patients presenting with anterior ST-segment elevation myocardial infarction &#40;STEMI&#41; without cardiogenic shock.</li> <li>Data from 50 patients showed unloading first and delaying reperfusion by 1/2 hour did not increase 30-day adverse cardiovascular and cerebrovascular events or infarct size (degree of heart muscle damage) compared to immediate reperfusion. In addition, unloading the left ventricle for 30 minutes prior to reperfusion appeared to reduce infarct size as measured by the percentage of area at risk in patients with an ST sum greater than six. Investors were apparently expecting a more definitive effect on infarct size.</li> <li>Co-lead investigator Navin Kapur, M.D. says, \u201cIf a reduction of infarct size from unloading before reperfusion is confirmed in a future trial, this concept would enhance the existing guidelines of immediate reperfusion for STEMI patients. 75% of patients experiencing their first heart attack will develop heart failure within five years, so new approaches are needed to reduce infarct size and prevent heart failure. Pre-clinical non-human data sets show unloading the left ventricle prior to reperfusion activates a cardioprotective program that reduces reperfusion injury, and could improve the current standard of care.\u201d</li> <li>A pivot trial comparing unloading with delayed perfusion with standard-of-care treatment will launch in 2019.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408500\" data-linked=\"Abiomed down 11% despite positive Impella CP data\" data-tweet=\"$ABMD - Abiomed down 11% despite positive Impella CP data https://seekingalpha.com/news/3408500-abiomed-down-11-despite-positive-impella-cp-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3408500-abiomed-down-11-despite-positive-impella-cp-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408497\" data-ts=\"1542034053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTG\" target=\"_blank\">PSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408497-piper-negative-on-pure-storage-after-reseller-survey\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper negative on Pure Storage after reseller survey</a></h4><ul>\n<li>        Piper Jaffray goes negative on Pure Storage (NYSE:<a href='https://seekingalpha.com/symbol/PSTG' title='Pure Storage'>PSTG</a>) after the firm\u2019s tech survey shows sharp Q3 declines with 35% of resellers below plan.</li>\n<li>               Piper says Pure Storage exceeded the high end of its guidance for 11 straight quarters, but the firm is concerned with demand declines, particularly as Dell\u2019s trends improve. </li>\n<li>               Source: <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a>.   </li>\n<li>               Pure Storage shares are <font color=\"red\">down 5.2%</font> to $19.75.    </li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408497\" data-linked=\"Piper negative on Pure Storage after reseller survey\" data-tweet=\"$PSTG - Piper negative on Pure Storage after reseller survey https://seekingalpha.com/news/3408497-piper-negative-on-pure-storage-after-reseller-survey?source=tweet\" data-url=\"https://seekingalpha.com/news/3408497-piper-negative-on-pure-storage-after-reseller-survey\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408493\" data-ts=\"1542033585\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HCLP\" target=\"_blank\">HCLP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408493-hi-crush-announces-new-sand-supply-agreement-chesapeake-energy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hi-Crush announces new sand supply agreement with Chesapeake Energy</a></h4><ul>\n<li>Hi-Crush Partners (<a href='https://seekingalpha.com/symbol/HCLP' title='Hi-Crush Partners LP'>HCLP</a> <font color='green'>+3.1%</font>) says it entered into a <a href=\"https://seekingalpha.com/pr/17330233-hi-crush-announces-integrated-agreement-northern-white-frac-sand-chesapeake-energy\" target=\"_blank\">new long-term frac sand supply agreement</a> for the in-basin purchase of Northern White frac sand to support Chesapeake Energy's (<a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color='red'>-0.3%</font>) completions program in the Marcellus and Powder River Basins.</li>\n<li>HCLP says CHK will utilize a PropStream container crew and related logistics with the option to expand based on demand.</li>\n<li>HCLP says the deal affirms the value of its operating strategy and as the ongoing demand for Northern White frac sand.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408493\" data-linked=\"Hi-Crush announces new sand supply agreement with Chesapeake Energy\" data-tweet=\"$HCLP $HCR $CHK - Hi-Crush announces new sand supply agreement with Chesapeake Energy https://seekingalpha.com/news/3408493-hi-crush-announces-new-sand-supply-agreement-chesapeake-energy?source=tweet\" data-url=\"https://seekingalpha.com/news/3408493-hi-crush-announces-new-sand-supply-agreement-chesapeake-energy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408492\" data-ts=\"1542033541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISCA\" target=\"_blank\">ISCA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408492-international-speedway-trades-over-nascar-offer-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Speedway trades over NASCAR offer price</a></h4><ul> <li>International Speedway (<a href='https://seekingalpha.com/symbol/ISCA' title='International Speedway Corporation'>ISCA</a> <font color='green'>+8.8%</font>) flies past the $42 offer price from NASCAR in opening trading.</li> <li>Shares rose to as high as $42.77, a level still far short of the 52-week high of $49.95.</li> <li>International Speedway has a special committee up and running to consider the NASCAR proposal. The France family says it doesn't plan to sell its ISC stake if the <a href=\"https://seekingalpha.com/pr/17329466-nascar-makes-offer-acquire-international-speedway-corporation\" target=\"_blank\">deal</a> if rejected.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408492\" data-linked=\"International Speedway trades over NASCAR offer price\" data-tweet=\"$ISCA - International Speedway trades over NASCAR offer price https://seekingalpha.com/news/3408492-international-speedway-trades-over-nascar-offer-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3408492-international-speedway-trades-over-nascar-offer-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:39 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408491\" data-ts=\"1542033496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BZUN\" target=\"_blank\">BZUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408491-baozunminus-15-on-singles-day-growth-deceleration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Baozun -15% on Singles&#39; Day growth deceleration</a></h4><ul>\n<li>        Baozun (NASDAQ:<a href='https://seekingalpha.com/symbol/BZUN' title='Baozun'>BZUN</a>) <a href=\"https://seekingalpha.com/pr/17329798-baozun-records-total-order-value-rmb6_55-billion-2018-singles-day\" target=\"_blank\">reports</a> its total order value for Singles' Day was up 31% Y/Y to a record RMB6.55B, which decelerated from the doubled growth in the past two years.</li>\n<li>               Baozun shares are<font color=\"red\"> down 15.4%</font> to $34.01.       </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408337-alibaba-sets-singles-day-sales-record\" target=\"_blank\">Alibaba sets Singles' Day sales record</a> (Nov. 11)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408491\" data-linked=\"Baozun -15% on Singles&#39; Day growth deceleration\" data-tweet=\"$BZUN - Baozun -15% on Singles&#39; Day growth deceleration https://seekingalpha.com/news/3408491-baozunminus-15-on-singles-day-growth-deceleration?source=tweet\" data-url=\"https://seekingalpha.com/news/3408491-baozunminus-15-on-singles-day-growth-deceleration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408486\" data-ts=\"1542032985\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNSR\" target=\"_blank\">FNSR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408486-finisar-upgraded-goldman-trimmed-craig-hallum-after-buyout-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Finisar upgraded at Goldman, trimmed at Craig-Hallum after buyout deal</a></h4><ul>   <li>Finisar (NASDAQ:<a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a>) is <font color=\"red\">down 4.3%</font> premarket as more reactions come in to its deal to be acquired at a 38% premium by II-VI, and many investors take some Friday profits.</li>    <li>Shares had <font color=\"green\">jumped 15.4%</font> Friday after news of the deal.</li>    <li>Craig-Hallum has downgraded <a href='https://seekingalpha.com/symbol/FNSR' title='Finisar Corporation'>FNSR</a> to Hold from Buy, a common reaction after the share jump moved the company closer to many analysts' fair value. The firm raised its price target to $24 from $23, implying 10% upside.</li>    <li>Meanwhile, Goldman Sachs took off its Sell rating based on the acquisition deal and moved up to Neutral. It's raised its target to $21 from $17.</li>    <li><a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a> is <font color=\"red\">down 5.3%</font> premarket; it <font color=\"red\">declined 18.9%</font> during the regular session Friday.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408263-finisar-ii-vi-analysts-react-buyout-deal\" target=\"_blank\">Finisar up, II-VI down: Analysts react to buyout deal</a> (Nov. 09 2018)</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408036-ii-vi-buying-finisar-38-percent-premium\" target=\"_blank\">II-VI buying Finisar at 38% premium</a> (Nov. 09 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3408486\" data-linked=\"Finisar upgraded at Goldman, trimmed at Craig-Hallum after buyout deal\" data-tweet=\"$FNSR $FNSR $IIVI - Finisar upgraded at Goldman, trimmed at Craig-Hallum after buyout deal https://seekingalpha.com/news/3408486-finisar-upgraded-goldman-trimmed-craig-hallum-after-buyout-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3408486-finisar-upgraded-goldman-trimmed-craig-hallum-after-buyout-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408485\" data-ts=\"1542032876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTI\" target=\"_blank\">APTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408485-apti-kodk-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">APTI, KODK among premarket gainers</a></h4><ul>\n<li>Apptio (NASDAQ:<a href='https://seekingalpha.com/symbol/APTI' title='Apptio'>APTI</a>) <font color=\"green\">+52%</font> on <a href=\"https://seekingalpha.com/news/3408352-wsj-apptio-taken-private-vista-equity-partners-38-share\" target=\"_blank\">going private</a> by Vista Equity Partners for $38/share.</li>\n<li>Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a>) <font color=\"green\">+23%</font> after asset sale.</li>\n<li>Matinas BioPharma Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/MTNB' title='Matinas Biopharma Holdings, Inc.'>MTNB</a>) <font color=\"green\">+17%</font> on Q3 <a href=\"https://seekingalpha.com/news/3408381-matinas-biopharma-holdings-beats-0_01\" target=\"_blank\">result</a>.</li>\n<li>Eidos Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/EIDX' title='Eidos Therapeutics'>EIDX</a>) <font color=\"green\">+14%</font> <a href=\"https://seekingalpha.com/pr/17329686-eidos-therapeutics-announces-positive-phase-2-data-ag10-symptomatic-patients-mutant-wild-type\" target=\"_blank\">positive results</a> of its Phase 2 clinical trial studying AG10 in subjects with symptomatic transthyretin amyloidosis cardiomyopathy.</li>\n<li>athenahealth (NASDAQ:<a href='https://seekingalpha.com/symbol/ATHN' title='athenahealth, Inc.'>ATHN</a>) <font color=\"green\">+9%</font> on being <a href=\"https://seekingalpha.com/news/3408463-athenahealth-acquired-5_7b-cash-shares-8-percent-premarket\" target=\"_blank\">acquired</a>.</li>\n<li>Pain Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a>) <font color=\"green\">+9% </font>on <a href=\"https://seekingalpha.com/pr/17329943-pain-therapeutics-appeals-fda-decision-remoxy\" target=\"_blank\">appeal</a> to FDA on decision of REMOXY.</li>\n<li>Lannett (NYSEMKT:<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a>) <font color=\"green\">+8%</font> on levothyroxine <a href=\"https://seekingalpha.com/news/3408398-lannett-11-percent-premarket-levothyroxine-deal-amneal\" target=\"_blank\">deal</a> with Amneal.</li>\n<li>OPKO Health (NYSEMKT:<a href='https://seekingalpha.com/symbol/OPK' title='OPKO Health, Inc.'>OPK</a>) <font color=\"green\">+7%</font>. on Q3 <a href=\"https://seekingalpha.com/news/3408251-opko-health-beats-0_02-misses-revenue\" target=\"_blank\">result</a>.</li>\n<li>ZIOPHARM Oncology (NASDAQ:<a href='https://seekingalpha.com/symbol/ZIOP' title='ZIOPHARM Oncology, Inc.'>ZIOP</a>) <font color=\"green\">+6%</font> on $50M <a href=\"https://seekingalpha.com/news/3408443-ziopharm-2-percent-premarket-50m-capital-raise-advancement-ad-rts-hilminus-12\" target=\"_blank\">capital raise</a> and advancement of Ad-RTS-hIL-12.</li>\n<li>California Resources (NYSEMKT:<a href='https://seekingalpha.com/symbol/CRC' title='California Resources Corporation'>CRC</a>) <font color=\"green\">+5%</font>.</li>\n<li>Organovo Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a>) <font color=\"green\">+5%</font>.</li>\n<li>Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a>) <font color=\"green\">+5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408485\" data-linked=\"APTI, KODK among premarket gainers\" data-tweet=\"$APTI $APTI $KODK - APTI, KODK among premarket gainers https://seekingalpha.com/news/3408485-apti-kodk-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3408485-apti-kodk-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3408478\" data-ts=\"1542032392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3408478-analysts-negative-on-iphone-shipments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts negative on iPhone shipments</a></h4><ul>\n<li>        Longbow Research says its Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) checks indicate iPhone order cuts of 20% to 30% mainly for the XR and XS Max, which will be partially offset by order increases for the 8, 8 Plus, and older models.</li>\n<li>                  JPMorgan is also out negative expecting iPhone order cuts and margin headwinds. The firm sees iPhone XR mix now at 39% of new iPhones in 2H18, down from the previous 47% mix forecast.    </li>\n<li>                  Source: StreetAccount.    </li>\n<li>               Apple shares are<font color=\"red\"> down 2.4%</font> premarket to $199.60.  </li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3408446-apple-slips-supplier-cuts-guidance\" target=\"_blank\">Apple slips after supplier cuts guidance</a> (Nov. 12)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3408478\" data-linked=\"Analysts negative on iPhone shipments\" data-tweet=\"$AAPL - Analysts negative on iPhone shipments https://seekingalpha.com/news/3408478-analysts-negative-on-iphone-shipments?source=tweet\" data-url=\"https://seekingalpha.com/news/3408478-analysts-negative-on-iphone-shipments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}